Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,OR[95%CI],P_value
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",18156,158,1.44 [1.22-1.69],8.757125720327982e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACE,Angiotensin-converting enzyme,16290,140,2.94 [1.77-4.90],3.223728625359416e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACE2,Angiotensin-converting enzyme 2,18206,158,1.84 [1.49-2.28],1.3622534089130476e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACHE,Acetylcholinesterase,15945,138,1.81 [1.16-2.82],0.0092789187830722
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACOT13,Acyl-coenzyme A thioesterase 13,16196,139,1.19 [1.02-1.38],0.0250472795221027
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,18584,161,1.33 [1.05-1.69],0.0194914087494843
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACP1,Low molecular weight phosphotyrosine protein phosphatase,15792,137,0.60 [0.39-0.91],0.0167284534967685
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACP5,Tartrate-resistant acid phosphatase type 5,18679,162,1.69 [1.15-2.47],0.0074986539483142
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACP6,Lysophosphatidic acid phosphatase type 6,18693,163,1.34 [1.06-1.70],0.0155303389978388
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACRV1,Acrosomal protein SP-10,15792,137,1.18 [1.04-1.33],0.0123345067166075
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACTA2,"Actin, aortic smooth muscle",18206,158,1.45 [1.12-1.88],0.0044809982404586
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACVRL1,Serine/threonine-protein kinase receptor R3,18368,157,3.07 [2.01-4.71],2.5468730255673784e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACY1,Aminoacylase-1,18584,161,1.33 [1.07-1.64],0.0088285401472053
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,15718,133,1.44 [1.08-1.90],0.0115180884453109
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADA,Adenosine deaminase,18753,162,1.54 [1.06-2.22],0.0224315401891403
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADA2,Adenosine deaminase 2,18477,160,2.38 [1.78-3.18],4.179179098759858e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,15792,137,3.22 [2.24-4.61],2.2966343798355319e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,18206,158,1.78 [1.12-2.82],0.0149113924555391
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,18691,161,2.04 [1.33-3.11],0.0010492738672565
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,16196,139,2.58 [1.63-4.09],5.263592388730104e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,15792,137,2.11 [1.44-3.10],0.000124633404832
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,18801,163,0.30 [0.18-0.52],1.3791904943056971e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,15792,137,1.84 [1.17-2.88],0.0080573068914287
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTSL2,ADAMTS-like protein 2,16282,139,4.06 [2.79-5.91],2.485654817422917e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRD1,Adhesion G-protein coupled receptor D1,15945,138,2.88 [2.04-4.08],2.3246344618850206e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRE1,Adhesion G protein-coupled receptor E1,16196,139,1.60 [1.22-2.09],0.0005974648490294
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRE2,Adhesion G protein-coupled receptor E2,18660,162,1.74 [1.07-2.84],0.0264372214325111
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRF5,Adhesion G protein-coupled receptor F5,16274,138,1.81 [1.01-3.23],0.0455770098854746
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRG1,Adhesion G-protein coupled receptor G1,18490,159,1.52 [1.34-1.74],3.0437801280042975e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRG2,Adhesion G-protein coupled receptor G2,18584,161,0.58 [0.37-0.92],0.0203870056791395
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADM,Pro-adrenomedullin,18723,163,3.49 [2.06-5.90],3.251918762495444e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AFP,Alpha-fetoprotein,18330,156,0.78 [0.62-0.98],0.0345391379442796
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGRN,Agrin,18660,162,2.34 [1.72-3.19],6.54038431115597e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGXT,Serine--pyruvate aminotransferase,18584,161,1.27 [1.07-1.52],0.0067202094626569
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AIF1,Allograft inflammatory factor 1,18156,158,1.47 [1.12-1.94],0.0057618755032044
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",18466,159,1.30 [1.14-1.48],8.708896878525599e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",18495,160,1.31 [1.11-1.54],0.0013880937814737
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",16246,139,1.75 [1.29-2.37],0.0002866669425503
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALPP,"Alkaline phosphatase, placental type",18490,159,1.14 [1.01-1.28],0.0304336933817757
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMBP,Protein AMBP,18690,162,2.68 [1.41-5.11],0.0026823810746778
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANG,Angiogenin,18548,161,2.31 [1.61-3.29],4.426556494851446e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPT2,Angiopoietin-2,18723,163,2.99 [2.20-4.07],3.3861203927956805e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL1,Angiopoietin-related protein 1,18332,156,2.07 [1.25-3.42],0.0046721921485113
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL4,Angiopoietin-related protein 4,18629,162,2.12 [1.56-2.88],1.6597533287771602e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL7,Angiopoietin-related protein 7,18723,163,1.53 [1.06-2.20],0.0221575203201805
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA2,Annexin A2,15617,134,1.38 [1.13-1.67],0.0012787110824124
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AOC3,Membrane primary amine oxidase,18671,161,1.88 [1.19-2.97],0.0071283232757736
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,18490,159,1.39 [1.04-1.88],0.028669700810559
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APLP1,Amyloid-like protein 1,18584,161,0.52 [0.39-0.69],5.354796325781978e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOA1,Apolipoprotein A-I,16302,138,0.48 [0.25-0.93],0.0287455155444322
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOC1,Apolipoprotein C-I,16272,137,0.34 [0.22-0.53],9.064205772053876e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOF,Apolipoprotein F,16290,140,0.47 [0.30-0.71],0.0004151389599288
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOM,Apolipoprotein M,18634,161,0.48 [0.30-0.77],0.0021911110552563
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AREG,Amphiregulin,18490,159,2.72 [2.13-3.48],8.907941857783628e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARG1,Arginase-1,18441,158,0.69 [0.52-0.91],0.0081964673850901
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGEF5,Rho guanine nucleotide exchange factor 5,15723,135,1.26 [1.01-1.57],0.0371398921311735
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARL13B,ADP-ribosylation factor-like protein 13B,15718,133,1.29 [1.03-1.61],0.0282582209639459
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARSB,Arylsulfatase B,18490,159,1.29 [1.01-1.66],0.0432752809568512
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ART3,Ecto-ADP-ribosyltransferase 3,18671,161,1.44 [1.01-2.05],0.0430557336057583
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASAH1,Acid ceramidase,16100,139,1.64 [1.23-2.18],0.0007053926982345
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASAH2,Neutral ceramidase,18398,157,0.63 [0.52-0.77],8.38659346889867e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASGR1,Asialoglycoprotein receptor 1,18398,157,2.54 [1.68-3.84],1.0040056241237044e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASGR2,Asialoglycoprotein receptor 2,16290,140,1.84 [1.04-3.28],0.0372558082290162
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,15718,133,1.39 [1.07-1.80],0.0144095035317065
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,15718,133,1.65 [1.03-2.65],0.0375058632134216
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP6AP2,Renin receptor,18156,158,1.37 [1.00-1.89],0.0482628421587823
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP6V1F,V-type proton ATPase subunit F,18121,155,1.24 [1.00-1.54],0.0466784650042699
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATRAID,All-trans retinoic acid-induced differentiation factor,16196,139,1.99 [1.36-2.89],0.0003421384781404
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATRN,"Attractin, Isoform 2",16302,138,0.28 [0.10-0.75],0.0115221660766881
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B2M,Beta-2-microglobulin,16302,138,1.87 [1.42-2.46],8.364508272833733e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",15876,134,2.20 [1.38-3.50],0.0009341382692769
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B4GALT1,"Beta-1,4-galactosyltransferase 1",18660,162,3.13 [1.97-4.95],1.174369473040104e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B4GAT1,"Beta-1,4-glucuronyltransferase 1",18585,160,0.43 [0.24-0.77],0.0044245999769572
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,18156,158,1.29 [1.05-1.60],0.0172941664701741
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAMBI,BMP and activin membrane-bound inhibitor homolog,18156,158,1.92 [1.25-2.93],0.0027367471146794
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAX,Apoptosis regulator BAX,18124,154,1.20 [1.02-1.42],0.0321525360252091
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAM,Basal cell adhesion molecule,18585,160,2.47 [1.50-4.08],0.0003981227573994
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAN,Brevican core protein,18398,157,0.34 [0.23-0.50],7.377575458360744e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",16274,138,1.71 [1.05-2.80],0.0326403682205154
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCHE,Cholinesterase,15990,134,0.42 [0.27-0.65],9.820029115464082e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",18533,160,1.59 [1.11-2.29],0.0116142918673241
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BIN2,Bridging integrator 2,18585,160,1.23 [1.05-1.45],0.0111006469802765
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BMP4,Bone morphogenetic protein 4,18368,157,1.44 [1.10-1.90],0.008553886187922
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BMP6,Bone morphogenetic protein 6,18180,158,1.69 [1.21-2.38],0.0023892582482196
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BMPER,BMP-binding endothelial regulator protein,15945,138,3.41 [2.05-5.67],2.395798856934005e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,15792,137,1.63 [1.15-2.31],0.0058211051446318
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BOC,Brother of CDO,18206,158,2.69 [1.48-4.90],0.001243531259225
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BPIFB1,BPI fold-containing family B member 1,18529,161,1.28 [1.02-1.60],0.0314253532596638
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRK1,Protein BRICK1,18150,155,1.51 [1.10-2.08],0.0105476363174669
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BSG,Basigin,18722,162,5.02 [2.81-8.96],4.64535979447299e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BST2,Bone marrow stromal antigen 2,18723,162,1.72 [1.40-2.10],1.899895144572557e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTD,Biotinidase,16302,138,0.34 [0.16-0.72],0.0050703022967799
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTN2A1,Butyrophilin subfamily 2 member A1,18660,162,2.91 [1.88-4.50],1.649336899555146e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTN3A2,Butyrophilin subfamily 3 member A2,18533,160,1.96 [1.44-2.67],2.1516154977901923e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QA,Complement C1q subcomponent subunit A,18661,160,3.55 [2.03-6.22],9.455696278262374e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,18671,161,2.03 [1.52-2.70],1.291715335458014e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,15945,138,2.50 [1.61-3.88],4.306133949883503e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,16246,139,1.55 [1.03-2.33],0.0354423734938384
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C3,Complement C3,15468,130,1.56 [1.16-2.11],0.0035083085014433
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C7,Complement component C7,15880,135,4.83 [3.17-7.36],2.0392831078931762e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C9,Complement component C9,16290,140,1.40 [1.02-1.91],0.0356993215406605
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA12,Carbonic anhydrase 12,18490,159,2.03 [1.36-3.03],0.0005602640794941
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA14,Carbonic anhydrase 14,18723,163,0.61 [0.41-0.90],0.0128502361282956
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA4,Carbonic anhydrase 4,18801,163,2.05 [1.15-3.65],0.0144910948460901
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA5A,"Carbonic anhydrase 5A, mitochondrial",18206,158,1.23 [1.07-1.41],0.0038088780134428
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA6,Carbonic anhydrase 6,18540,160,0.80 [0.64-0.99],0.0387796698152756
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA9,Carbonic anhydrase 9,18723,163,1.38 [1.07-1.78],0.013777133095405
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALCA,Calcitonin,18369,157,1.48 [1.27-1.73],4.170162260634272e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALCB,Calcitonin gene-related peptide 2,16250,141,1.52 [1.10-2.10],0.0111152539871735
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALY,Neuron-specific vesicular protein calcyon,15718,133,1.61 [1.17-2.21],0.0034514698266341
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,16246,139,1.22 [1.05-1.43],0.0119197937219747
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CANT1,Soluble calcium-activated nucleotidase 1,18525,161,2.01 [1.03-3.92],0.041508401679816
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAPG,Macrophage-capping protein,18408,158,1.29 [1.01-1.65],0.0423592295745804
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP4,Caspase-4,15972,137,1.10 [1.00-1.20],0.0390827593116736
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBLN1,Cerebellin-1,15723,135,1.17 [1.01-1.36],0.0357418923196528
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBLN4,Cerebellin-4,18723,163,0.49 [0.32-0.74],0.0007129768364991
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBS,Cystathionine beta-synthase,15876,134,1.59 [1.20-2.12],0.0014295827795669
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCDC80,Coiled-coil domain-containing protein 80,18584,161,2.33 [1.69-3.19],1.732952535802917e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL11,Eotaxin,18753,162,1.54 [1.05-2.25],0.0272562519331955
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL14,C-C motif chemokine 14,18548,161,1.61 [1.19-2.17],0.0020098017583262
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL15,C-C motif chemokine 15,18801,163,1.87 [1.42-2.47],8.823375526600438e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL16,C-C motif chemokine 16,18801,163,1.81 [1.36-2.42],5.328192421652661e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL17,C-C motif chemokine 17,18551,162,1.24 [1.07-1.44],0.0035890579850511
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL20,C-C motif chemokine 20,18753,162,1.41 [1.25-1.59],1.3350750736738151e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL21,C-C motif chemokine 21,18660,162,2.12 [1.74-2.58],1.3649521980274196e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL22,C-C motif chemokine 22,18431,162,1.32 [1.04-1.69],0.0248574557875092
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL23,C-C motif chemokine 23,18660,162,1.46 [1.05-2.03],0.0227319530124839
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL27,C-C motif chemokine 27,18584,161,1.34 [1.05-1.70],0.0188093365835097
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL28,C-C motif chemokine 28,18474,160,1.39 [1.12-1.73],0.0029970138474085
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL3,C-C motif chemokine 3,18533,160,1.30 [1.07-1.58],0.0075465022325756
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL5,C-C motif chemokine 5,18671,161,1.17 [1.01-1.34],0.0319050404460888
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL7,C-C motif chemokine 7,18533,160,1.36 [1.10-1.67],0.0041700333291525
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN3,CCN family member 3,18772,161,2.12 [1.51-2.97],1.2605919216043737e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN4,CCN family member 4,18723,163,1.82 [1.32-2.52],0.0002893510354384
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN5,CCN family member 5,18585,160,1.53 [1.10-2.13],0.0121207255252479
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD14,Monocyte differentiation antigen CD14,18240,158,1.93 [1.42-2.62],2.2668882743917253e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD163,Scavenger receptor cysteine-rich type 1 protein M130,18671,161,1.75 [1.29-2.36],0.0002832765563125
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD1C,T-cell surface glycoprotein CD1c,18648,157,0.58 [0.34-1.00],0.049111468991469
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD207,C-type lectin domain family 4 member K,18173,156,1.57 [1.08-2.27],0.0171851017003227
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD209,CD209 antigen,18630,160,0.61 [0.42-0.88],0.0090235308442337
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD248,Endosialin,16282,139,0.55 [0.36-0.84],0.0056038601226301
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD27,CD27 antigen,18648,157,2.38 [1.83-3.11],1.3965714884875679e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD274,Programmed cell death 1 ligand 1,18398,157,2.56 [1.89-3.46],1.0223042815965195e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD276,CD276 antigen,18581,162,2.37 [1.62-3.48],9.860133005482774e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300A,CMRF35-like molecule 8,15945,138,1.73 [1.04-2.90],0.0359422642034076
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300C,CMRF35-like molecule 6,18723,162,2.14 [1.48-3.09],5.0010050702324186e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300E,CMRF35-like molecule 2,18661,163,2.33 [1.76-3.09],2.945123205612372e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300LF,CMRF35-like molecule 1,18723,163,1.66 [1.28-2.16],0.0001170168475789
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD302,CD302 antigen,18490,159,2.77 [1.94-3.96],2.4267093899219357e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD34,Hematopoietic progenitor cell antigen CD34,18669,162,0.49 [0.27-0.88],0.0163860150859788
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,18490,159,1.76 [1.24-2.51],0.0016651460762953
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD4,T-cell surface glycoprotein CD4,18512,160,2.07 [1.49-2.89],1.4885748778375784e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD40,Tumor necrosis factor receptor superfamily member 5,18573,162,1.85 [1.43-2.40],3.499655888505572e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD46,Membrane cofactor protein,18488,161,1.92 [1.24-2.97],0.0036142258771074
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD48,CD48 antigen,18629,162,2.32 [1.50-3.60],0.0001656489122911
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD5,T-cell surface glycoprotein CD5,18690,162,1.54 [1.09-2.18],0.0134204533014736
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD55,Complement decay-accelerating factor,17944,154,1.97 [1.21-3.19],0.0061749310884426
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD59,CD59 glycoprotein,17947,159,2.45 [1.59-3.79],5.395757873768819e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD5L,CD5 antigen-like,16208,136,2.15 [1.53-3.01],8.523871008417595e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD63,CD63 antigen,18368,157,1.44 [1.08-1.93],0.0133827042891696
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD69,Early activation antigen CD69,18505,161,1.19 [1.00-1.40],0.0453754751027668
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD7,T-cell antigen CD7,15755,136,1.66 [1.20-2.29],0.0021541722154221
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD74,HLA class II histocompatibility antigen gamma chain,18723,162,2.72 [1.92-3.84],1.344405738317692e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD79B,B-cell antigen receptor complex-associated protein beta chain,18753,162,1.82 [1.43-2.31],1.296219749950551e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD80,T-lymphocyte activation antigen CD80,16274,138,2.82 [1.90-4.19],2.4895974504983413e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD83,CD83 antigen,18533,160,1.91 [1.33-2.74],0.0004039690122371
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD93,Complement component C1q receptor,17916,155,1.65 [1.06-2.56],0.0260035888114198
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD99,CD99 antigen,18585,160,3.19 [1.74-5.83],0.00016643701382
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD99L2,CD99 antigen-like protein 2,18585,160,2.06 [1.18-3.60],0.011056840700153
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDCP1,CUB domain-containing protein 1,18398,157,1.67 [1.33-2.11],1.3006180617417258e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH2,Cadherin-2,18584,161,1.84 [1.25-2.71],0.0018778126795854
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH3,Cadherin-3,18723,162,1.73 [1.23-2.42],0.0014780865568624
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDHR2,Cadherin-related family member 2,18490,159,1.48 [1.22-1.80],6.436210658751131e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDHR5,Cadherin-related family member 5,18584,161,0.42 [0.31-0.58],1.663683015144825e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDSN,Corneodesmosin,18702,162,1.53 [1.12-2.09],0.0076066651602131
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,18616,155,3.09 [1.63-5.85],0.0005400529584448
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,16196,139,0.44 [0.37-0.54],4.128845036283206e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,16196,139,2.14 [1.51-3.04],1.91872581528146e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,15972,137,1.36 [1.02-1.81],0.0372883341627054
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,18533,160,1.21 [1.03-1.41],0.021193333358549
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,17948,157,1.42 [1.19-1.70],0.0001006873741292
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,16282,139,2.03 [1.54-2.68],5.740083342822433e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,18206,158,1.64 [1.28-2.11],0.0001050716728609
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CELA2A,Chymotrypsin-like elastase family member 2A,16282,139,0.72 [0.58-0.91],0.0053114022956854
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CELA3A,Chymotrypsin-like elastase family member 3A,18771,163,0.71 [0.57-0.88],0.0016677876740089
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP20,Centrosomal protein 20,18156,158,1.24 [1.02-1.50],0.028318702861588
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CETN2,Centrin-2,18150,155,1.25 [1.01-1.55],0.0412336649522229
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFD,Complement factor D,16302,138,2.80 [1.46-5.38],0.0019830450146077
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFP,Properdin,16302,138,0.21 [0.09-0.47],0.0001230214546527
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGA,Glycoprotein hormones alpha chain,18585,160,0.86 [0.74-0.98],0.0286944890147945
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGREF1,Cell growth regulator with EF hand domain protein 1,18584,161,1.85 [1.37-2.51],7.120347223933367e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",16250,141,2.17 [1.63-2.88],1.0788211822731923e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHCHD6,MICOS complex subunit MIC25,16206,140,2.41 [1.64-3.55],8.12964080176286e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHGA,Chromogranin-A,16282,139,1.38 [1.20-1.57],3.676210082100144e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHI3L1,Chitinase-3-like protein 1,18206,159,1.60 [1.39-1.84],2.5399732875736817e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHRDL1,Chordin-like protein 1,18629,162,2.38 [1.60-3.54],2.0701337545810144e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHRDL2,Chordin-like protein 2,18584,161,1.54 [1.16-2.05],0.002693033654431
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CILP,Cartilage intermediate layer protein 1,16282,139,1.96 [1.43-2.67],2.689182843525441e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKAP4,Cytoskeleton-associated protein 4,18667,162,2.82 [1.94-4.11],5.545758558681485e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKB,Creatine kinase B-type,16282,139,1.71 [1.31-2.24],8.436384000827558e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",18521,162,1.25 [1.01-1.56],0.0448561546698331
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLC,Galectin-10,18554,161,1.23 [1.01-1.51],0.0381943213679767
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC10A,C-type lectin domain family 10 member A,18398,157,1.53 [1.02-2.29],0.0404531456781849
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC11A,C-type lectin domain family 11 member A,18556,160,1.77 [1.32-2.38],0.0001498782709281
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC12A,C-type lectin domain family 12 member A,15792,137,2.66 [1.30-5.42],0.0072332764394017
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC14A,C-type lectin domain family 14 member A,18585,160,2.32 [1.56-3.45],3.118193545556194e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC1A,C-type lectin domain family 1 member A,18206,158,2.30 [1.58-3.34],1.424229699216379e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC3B,Tetranectin,15917,134,0.12 [0.06-0.23],6.32696142715129e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4A,C-type lectin domain family 4 member A,18533,160,0.62 [0.43-0.90],0.0126040016915783
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4D,C-type lectin domain family 4 member D,18533,160,1.64 [1.33-2.03],4.961989473955355e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4M,C-type lectin domain family 4 member M,16251,139,0.60 [0.43-0.85],0.0037441492747408
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC5A,C-type lectin domain family 5 member A,18529,161,2.46 [1.63-3.73],2.0910349711641405e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC6A,C-type lectin domain family 6 member A,18156,158,2.07 [1.58-2.71],1.5430482063139904e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC7A,C-type lectin domain family 7 member A,18753,162,1.43 [1.07-1.92],0.0148220924498005
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLGN,Calmegin,15834,134,1.62 [1.22-2.15],0.0007633413978124
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLMP,CXADR-like membrane protein,18723,163,2.33 [1.30-4.16],0.0044628179349205
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",18369,157,1.19 [1.02-1.38],0.0253474225331829
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLPS,Colipase,18550,160,0.74 [0.62-0.89],0.0011863201163375
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLSTN2,Calsyntenin-2,18753,162,1.88 [1.41-2.51],1.671149865496572e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLSTN3,Calsyntenin-3,16250,141,2.20 [1.39-3.49],0.0007867057077891
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLU,Clusterin,16302,138,0.20 [0.07-0.55],0.0019263629654665
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNDP1,Beta-Ala-His dipeptidase,18671,161,0.46 [0.37-0.59],1.8717468343870432e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN1,Contactin-1,18801,163,0.40 [0.25-0.63],7.346789270255525e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN3,Contactin-3,18585,160,0.57 [0.37-0.89],0.0129121670444628
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN5,Contactin-5,18608,162,0.46 [0.32-0.66],3.19857415077757e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COCH,Cochlin,16274,138,1.41 [1.02-1.95],0.038125692511378
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL15A1,Collagen alpha-1(XV) chain,16282,139,2.04 [1.24-3.35],0.0047200235041386
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL18A1,Collagen alpha-1(XVIII) chain,18670,163,4.76 [2.82-8.05],5.469232154200894e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL24A1,Collagen alpha-1(XXIV) chain,16196,139,1.40 [1.03-1.89],0.0312124843203219
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL3A1,Collagen alpha-1(III) chain,16282,139,2.96 [1.49-5.88],0.0019086547913751
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL4A1,Collagen alpha-1(IV) chain,18584,161,2.72 [2.01-3.68],8.107878217967344e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL5A1,Collagen alpha-1(V) chain,15945,138,2.08 [1.46-2.97],5.17659113875261e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL6A3,Collagen alpha-3(VI) chain,18801,163,2.52 [1.89-3.36],2.8526484293083885e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL9A1,Collagen alpha-1(IX) chain,18533,160,1.39 [1.05-1.84],0.0234034460848201
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COLEC12,Collectin-12,18581,162,3.30 [2.15-5.05],4.029363901112768e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COMT,Catechol O-methyltransferase,18022,155,1.23 [1.03-1.48],0.0231920763967453
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",18490,159,1.37 [1.13-1.67],0.0015287152635447
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPA2,Carboxypeptidase A2,18668,162,0.76 [0.61-0.94],0.0130075265480097
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPA4,Carboxypeptidase A4,15628,138,1.61 [1.08-2.38],0.0185903794897187
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPB2,Carboxypeptidase B2,16272,137,0.27 [0.13-0.55],0.0003348658317248
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPM,Carboxypeptidase M,18627,162,1.63 [1.09-2.43],0.0174388316933202
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPVL,Probable serine carboxypeptidase CPVL,18694,162,1.48 [1.03-2.11],0.0333805481898629
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPXM1,Probable carboxypeptidase X1,18648,157,1.23 [1.01-1.50],0.0360195291299278
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPXM2,Inactive carboxypeptidase-like protein X2,16274,138,2.57 [1.57-4.20],0.00017261227729
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRACR2A,EF-hand calcium-binding domain-containing protein 4B,18156,158,1.22 [1.04-1.44],0.0167611308671487
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CREBZF,CREB/ATF bZIP transcription factor,15698,138,1.93 [1.09-3.41],0.024640682768108
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CREG1,Protein CREG1,18345,154,1.74 [1.27-2.40],0.0006508833732723
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRELD1,Protein disulfide isomerase CRELD1,15945,138,2.34 [1.55-3.53],4.936457859954838e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRELD2,Protein disulfide isomerase CRELD2,18629,162,1.46 [1.11-1.91],0.0061323868509588
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRH,Corticoliberin,18121,158,0.78 [0.66-0.94],0.0069664265482878
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRHBP,Corticotropin-releasing factor-binding protein,18581,162,1.81 [1.09-3.01],0.021971719229526
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRIM1,Cysteine-rich motor neuron 1 protein,18660,162,4.40 [2.39-8.12],2.1227806126200067e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRLF1,Cytokine receptor-like factor 1,18660,162,1.93 [1.11-3.33],0.0188401536142866
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRTAC1,Cartilage acidic protein 1,18801,163,0.35 [0.23-0.53],8.275478676294541e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRYBB2,Beta-crystallin B2,16250,141,1.23 [1.07-1.43],0.0050355872050961
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF1,Macrophage colony-stimulating factor 1,18660,162,4.17 [2.72-6.40],5.2760296100284996e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF1R,Macrophage colony-stimulating factor 1 receptor,16290,140,1.72 [1.18-2.49],0.0043683049882637
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,18398,157,1.29 [1.03-1.61],0.0255831261659902
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF2RB,Cytokine receptor common subunit beta,15792,137,1.60 [1.06-2.39],0.0237447191935627
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF3,Granulocyte colony-stimulating factor,18225,158,1.45 [1.11-1.89],0.007010931666277
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF3R,Granulocyte colony-stimulating factor receptor,15792,137,1.68 [1.01-2.80],0.0450559027137259
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSNK2A1,Casein kinase II subunit alpha,16246,139,1.43 [1.00-2.05],0.0484939528218989
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST1,Cystatin-SN,14183,125,1.19 [1.01-1.40],0.0324385833945091
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST3,Cystatin-C,18640,160,2.54 [1.73-3.72],1.7971211601189294e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST6,Cystatin-M,18090,153,1.36 [1.03-1.78],0.0296087741821901
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST7,Cystatin-F,18604,162,1.19 [1.06-1.33],0.0042047748524497
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSTB,Cystatin-B,18316,162,1.89 [1.41-2.53],2.0574500391396565e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTHRC1,Collagen triple helix repeat-containing protein 1,16282,139,3.35 [2.11-5.30],2.582209210705525e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTRB1,Chymotrypsinogen B,18585,160,0.71 [0.57-0.90],0.0037901238960321
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTRC,Chymotrypsin-C,18581,162,0.65 [0.54-0.79],1.6758271211123314e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTRL,Chymotrypsin-like protease CTRL-1,16250,141,0.73 [0.59-0.91],0.0039232322798707
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSC,Dipeptidyl peptidase 1,18540,161,1.53 [1.12-2.07],0.0068632860393176
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSD,Cathepsin D,17418,149,1.75 [1.35-2.26],2.1887378668661703e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSL,Cathepsin L1,18584,161,3.10 [1.84-5.24],2.198825850406522e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSO,Cathepsin O,18753,162,1.57 [1.02-2.39],0.0382802874200258
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSZ,Cathepsin Z,18619,161,2.08 [1.37-3.15],0.000577014496414
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXADR,Coxsackievirus and adenovirus receptor,18533,160,1.82 [1.43-2.31],7.719589709090253e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL10,C-X-C motif chemokine 10,18660,162,1.34 [1.11-1.62],0.0025553215016222
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL11,C-X-C motif chemokine 11,18723,162,1.40 [1.22-1.61],2.0644691376004884e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL12,Stromal cell-derived factor 1,18225,158,1.76 [1.26-2.47],0.0010094794770886
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL13,C-X-C motif chemokine 13,18723,162,1.48 [1.29-1.69],6.710232879482948e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL16,C-X-C motif chemokine 16,18774,163,2.39 [1.35-4.24],0.0027728015126282
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL17,C-X-C motif chemokine 17,18753,162,1.99 [1.53-2.59],3.255617583543831e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL8,Interleukin-8,18446,161,1.31 [1.11-1.54],0.001649189213649
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL9,C-X-C motif chemokine 9,18660,162,1.58 [1.32-1.88],3.7413126490263686e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYB5R2,NADH-cytochrome b5 reductase 2,16023,137,1.34 [1.01-1.78],0.044474308872209
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYTL1,Cytokine-like protein 1,16282,139,2.37 [1.37-4.11],0.0020542332256855
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAG1,Dystroglycan,18660,162,1.54 [1.13-2.09],0.0063027088019728
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",18648,157,1.78 [1.19-2.67],0.0050851778188222
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",18490,159,1.59 [1.19-2.13],0.0018380948685895
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDR1,Epithelial discoidin domain-containing receptor 1,18723,162,2.96 [1.81-4.86],1.7309445330671963e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX53,Probable ATP-dependent RNA helicase DDX53,15834,134,1.58 [1.02-2.46],0.0426267591710183
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFA1_DEFA1B,Neutrophil defensin 1,18217,157,1.30 [1.05-1.62],0.0166123694676758
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFB4A_DEFB4B,Beta-defensin 4A,18335,156,1.10 [1.00-1.20],0.0486797632368075
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DKK4,Dickkopf-related protein 4,18374,157,1.46 [1.13-1.90],0.004355756988328
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLL1,Delta-like protein 1,18648,157,2.94 [1.97-4.38],1.295384199956065e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DMD,Dystrophin,15876,134,1.46 [1.12-1.90],0.0049493143881183
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNM3,Dynamin-3,16246,139,1.53 [1.18-2.00],0.0015964081370915
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNMBP,Dynamin-binding protein,18398,157,1.39 [1.10-1.75],0.0057757856893027
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DOK2,Docking protein 2,18584,161,1.13 [1.00-1.27],0.0483015620224108
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP7,Dipeptidyl peptidase 2,18449,159,1.63 [1.31-2.04],1.1901431467344282e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPY30,Protein dpy-30 homolog,18658,163,1.52 [1.24-1.87],6.421916532393564e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSC2,Desmocollin-2,18401,157,2.16 [1.52-3.05],1.4433040904978554e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSG3,Desmoglein-3,18658,162,1.66 [1.14-2.42],0.008194078682174
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTNB,Dystrobrevin beta,16169,140,2.25 [1.63-3.09],6.680238431633517e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTX3,Probable E3 ubiquitin-protein ligase DTX3,18490,159,2.19 [1.35-3.57],0.0015872365408297
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",16196,139,1.21 [1.03-1.42],0.0181440407197214
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EBI3_IL27,Interleukin-27,18693,163,3.11 [2.07-4.67],4.7928892515879643e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",16274,138,1.34 [1.11-1.64],0.0029501795789412
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECHS1,"Enoyl-CoA hydratase, mitochondrial",15876,134,1.46 [1.23-1.73],1.0972036376221982e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECI2,Enoyl-CoA delta isomerase 2,15718,133,1.44 [1.14-1.82],0.0022465265599929
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDA2R,Tumor necrosis factor receptor superfamily member 27,18723,163,2.57 [1.95-3.38],1.8728077972749758e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDAR,Tumor necrosis factor receptor superfamily member EDAR,18533,160,0.78 [0.66-0.92],0.0025704305087761
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDDM3B,Epididymal secretory protein E3-beta,16206,140,1.33 [1.10-1.60],0.0031508598467504
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDF1,Endothelial differentiation-related factor 1,16246,139,1.26 [1.03-1.55],0.0244023913357161
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDN1,Endothelin-1,15876,134,3.61 [2.24-5.82],1.3054136662796125e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFCAB14,EF-hand calcium-binding domain-containing protein 14,16196,139,1.70 [1.14-2.53],0.0087769398606318
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,18644,161,3.14 [2.13-4.62],6.976144234892929e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNA1,Ephrin-A1,18558,160,2.05 [1.36-3.09],0.0006276093350202
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNA4,Ephrin-A4,18368,157,2.16 [1.55-3.01],4.635081945052191e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNB2,Ephrin-B2,15834,134,1.31 [1.02-1.70],0.0372530570270557
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFL7,Epidermal growth factor-like protein 7,18156,158,2.03 [1.47-2.79],1.6755712603167004e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGLN1,Egl nine homolog 1,18533,160,1.38 [1.15-1.66],0.0005259045427895
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",16123,139,1.17 [1.01-1.37],0.0423451294751728
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,15718,133,1.32 [1.05-1.67],0.0195578525688797
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,18753,162,1.18 [1.02-1.37],0.0312314391171891
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELN,Elastin,16274,138,1.57 [1.05-2.36],0.0286450270639645
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENAH,Protein enabled homolog,18225,158,1.40 [1.05-1.86],0.022619926669663
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENO1,Alpha-enolase,18547,160,1.21 [1.00-1.46],0.0487440925564215
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENO3,Beta-enolase,15876,134,0.71 [0.52-0.98],0.0350869631350614
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,18660,162,0.73 [0.55-0.97],0.0295212336022334
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,15876,134,0.64 [0.42-0.98],0.0387294385266025
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,17962,153,1.45 [1.22-1.73],2.328315133873627e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,18206,158,1.96 [1.09-3.54],0.0243034411720283
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENTR1,Endosome-associated-trafficking regulator 1,15876,134,1.44 [1.12-1.86],0.004534401795456
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA1,Ephrin type-A receptor 1,18634,162,1.69 [1.12-2.57],0.0130807553382761
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA2,Ephrin type-A receptor 2,17924,155,2.76 [2.00-3.81],8.177473247338147e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHB4,Ephrin type-B receptor 4,18801,163,3.09 [1.99-4.79],4.528011888394822e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPO,Erythropoietin,18533,160,1.40 [1.21-1.63],1.0108917279637743e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPPK1,Epiplakin,15876,134,1.37 [1.10-1.71],0.0052958947608123
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,18688,163,1.58 [1.03-2.42],0.0355069862739905
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERBB2,Receptor tyrosine-protein kinase erbB-2,18648,157,2.09 [1.16-3.76],0.0135251203119477
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERBB3,Receptor tyrosine-protein kinase erbB-3,18525,162,0.47 [0.23-0.95],0.0345997870845576
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ESAM,Endothelial cell-selective adhesion molecule,18801,163,1.97 [1.32-2.94],0.0009742932499344
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ESYT2,Extended synaptotagmin-2,16250,141,1.31 [1.08-1.60],0.007475534777395
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EXOSC10,Exosome component 10,15718,133,1.28 [1.01-1.63],0.0437462723581512
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F10,Coagulation factor X,16290,140,0.53 [0.30-0.93],0.0270548563860607
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F11,Coagulation factor XI,16072,136,0.30 [0.17-0.52],2.2387334150119745e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F11R,Junctional adhesion molecule A,18585,160,1.37 [1.06-1.76],0.0151228220510405
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F12,Coagulation factor XII,16302,138,0.65 [0.46-0.93],0.0184695035728361
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F13B,Coagulation factor XIII B chain,16208,136,0.46 [0.25-0.87],0.0174047721956947
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F2R,Proteinase-activated receptor 1,18629,162,1.31 [1.01-1.69],0.0390518645821053
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F7,Coagulation factor VII,18642,161,0.56 [0.37-0.86],0.0078275236299431
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP1,"Fatty acid-binding protein, liver",18581,162,1.45 [1.27-1.65],3.9434281360993175e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP2,"Fatty acid-binding protein, intestinal",18584,161,1.22 [1.03-1.43],0.0194261983066557
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP3,"Fatty acid-binding protein, heart",16274,138,1.48 [1.13-1.92],0.0038415914286889
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP5,Fatty acid-binding protein 5,18651,162,1.25 [1.02-1.53],0.0329615944261866
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM171A2,Protein FAM171A2,16246,139,1.11 [1.01-1.22],0.0361073662877869
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM20A,Pseudokinase FAM20A,16274,138,2.07 [1.23-3.47],0.005894006934984
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM3B,Protein FAM3B,18490,159,1.92 [1.25-2.93],0.00273246971498
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM3C,Protein FAM3C,18550,161,1.84 [1.21-2.80],0.0042993781806483
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAS,Tumor necrosis factor receptor superfamily member 6,18745,163,1.70 [1.29-2.24],0.0001788434217056
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FASLG,Tumor necrosis factor ligand superfamily member 6,18753,162,0.56 [0.39-0.79],0.0011536212255188
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FBLN2,Fibulin-2,16282,139,2.57 [1.65-4.01],3.275548196405259e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FBP1,"Fructose-1,6-bisphosphatase 1",18584,161,1.29 [1.08-1.55],0.0049152676710234
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,16274,138,1.26 [1.02-1.55],0.0350128140307436
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCAR,Immunoglobulin alpha Fc receptor,18533,160,2.04 [1.54-2.70],5.846731596567371e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCN2,Ficolin-2,18508,160,0.68 [0.49-0.94],0.0212356308661166
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRL1,Fc receptor-like protein 1,18584,161,0.62 [0.46-0.85],0.0024137071513886
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRL5,Fc receptor-like protein 5,18585,160,1.42 [1.15-1.77],0.0014283002878843
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRLB,Fc receptor-like B,18156,158,1.46 [1.25-1.70],1.1923550669219374e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FDX2,"Ferredoxin-2, mitochondrial",15718,133,1.41 [1.08-1.84],0.0114974253264524
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGA,Fibrinogen alpha chain,15928,133,1.94 [1.16-3.26],0.0116675122102071
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF21,Fibroblast growth factor 21,18693,163,1.43 [1.29-1.59],2.9373665740926716e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF23,Fibroblast growth factor 23,18697,163,1.47 [1.23-1.77],3.0286591676740657e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF6,Fibroblast growth factor 6,15792,137,1.42 [1.02-1.98],0.0378488511556573
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFBP1,Fibroblast growth factor-binding protein 1,18648,157,0.38 [0.25-0.57],2.6698852949011874e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFBP2,Fibroblast growth factor-binding protein 2,16282,139,0.63 [0.45-0.88],0.0063745643396689
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFR2,Fibroblast growth factor receptor 2,18648,157,4.83 [2.76-8.43],3.194274740897036e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFR4,Fibroblast growth factor receptor 4,15945,138,0.60 [0.44-0.83],0.0021262781914656
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGL1,Fibrinogen-like protein 1,16290,140,1.93 [1.56-2.39],1.5799710433747935e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGR,Tyrosine-protein kinase Fgr,18150,155,1.25 [1.01-1.54],0.0428685953804378
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,18398,157,1.45 [1.03-2.04],0.0321359283968304
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,18398,157,1.29 [1.10-1.52],0.0019711000208918
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,18398,157,2.61 [1.67-4.08],2.4742082952933616e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLT1,Vascular endothelial growth factor receptor 1,18457,159,2.10 [1.22-3.65],0.0079042849500934
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,16206,140,1.65 [1.08-2.51],0.0202943702559798
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOLR1,Folate receptor alpha,18580,156,1.72 [1.10-2.68],0.0168462198980606
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOLR2,Folate receptor beta,18723,162,2.13 [1.35-3.37],0.0012405743519131
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOS,Proto-oncogene c-Fos,15672,138,1.87 [1.15-3.04],0.0110637335206413
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FRMD4B,FERM domain-containing protein 4B,15718,133,1.29 [1.02-1.63],0.036315884091696
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSHB,Follitropin subunit beta,15876,134,0.68 [0.56-0.82],4.656836509140532e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FST,Follistatin,18629,162,1.47 [1.11-1.95],0.0065607854736714
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSTL3,Follistatin-related protein 3,18548,161,3.52 [2.52-4.91],1.592605708248617e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUOM,Fucose mutarotase,15945,138,1.62 [1.27-2.07],9.37746988036768e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,18723,162,2.54 [1.92-3.35],6.268745448653901e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FXN,"Frataxin, mitochondrial",18723,163,1.28 [1.05-1.55],0.0128357365953119
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,15876,134,1.55 [1.17-2.06],0.0024075384771974
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,18490,159,2.33 [1.42-3.82],0.0008332479738093
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,16274,138,2.33 [1.42-3.83],0.000835857127279
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAS6,Growth arrest-specific protein 6,18697,163,2.32 [1.36-3.95],0.0019087359155597
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GASK1A,Golgi-associated kinase 1A,15718,133,0.52 [0.34-0.77],0.0013720640111722
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAST,Gastrin,16250,141,1.22 [1.11-1.35],5.404428164444905e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",15876,134,1.34 [1.07-1.67],0.0102526885944967
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,15564,136,1.40 [1.05-1.86],0.0219633455312571
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",18490,159,2.05 [1.39-3.02],0.0002786471852019
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GDF15,Growth/differentiation factor 15,18801,163,2.49 [2.01-3.08],4.751151815452815e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GDNF,Glial cell line-derived neurotrophic factor,18150,155,1.53 [1.08-2.17],0.0158698480922677
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GET3,ATPase GET3,16274,138,1.36 [1.06-1.76],0.0175510219299542
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFER,FAD-linked sulfhydryl oxidase ALR,18156,158,1.35 [1.08-1.69],0.0080729982700477
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRA1,GDNF family receptor alpha-1,18693,163,2.74 [1.82-4.11],1.2452446324242249e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRA2,GDNF family receptor alpha-2,18490,159,2.13 [1.09-4.15],0.0261119743818585
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRAL,GDNF family receptor alpha-like,15758,137,0.54 [0.41-0.72],2.948420781257074e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGT1,Glutathione hydrolase 1 proenzyme,18558,160,1.84 [1.48-2.29],5.31572880001492e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGT5,Glutathione hydrolase 5 proenzyme,18398,157,2.46 [1.45-4.18],0.00087125340213
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GHR,Growth hormone receptor,15945,138,0.27 [0.15-0.48],5.98066794153608e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GHRL,Appetite-regulating hormone,18584,161,0.82 [0.70-0.96],0.0136101897277542
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLA,Alpha-galactosidase A,15920,138,2.19 [1.46-3.30],0.0001632933127026
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLB1,Beta-galactosidase,18398,157,1.46 [1.04-2.04],0.0267928079632582
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLO1,Lactoylglutathione lyase,18206,158,1.41 [1.11-1.79],0.0053644562761945
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",15945,138,1.21 [1.00-1.46],0.0493061965493075
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GM2A,Ganglioside GM2 activator,15864,136,1.70 [1.30-2.22],9.721664437854118e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNLY,Granulysin,18585,160,1.31 [1.01-1.71],0.0446867371727742
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GOT1,"Aspartate aminotransferase, cytoplasmic",16282,139,1.56 [1.13-2.15],0.0072640089073933
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPC5,Glypican-5,18398,157,0.58 [0.45-0.75],3.7829776132445374e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR15L,Protein GPR15L,16196,139,1.66 [1.30-2.13],4.740555607489463e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR37,Prosaposin receptor GPR37,18206,158,1.70 [1.39-2.09],2.407499528360521e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPRC5C,G-protein coupled receptor family C group 5 member C,16206,140,1.43 [1.13-1.81],0.0034239134890356
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRPEL1,"GrpE protein homolog 1, mitochondrial",18490,159,1.78 [1.47-2.15],1.9961325478367633e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSN,Gelsolin,16236,140,0.48 [0.28-0.83],0.0083987703721187
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSTM4,Glutathione S-transferase Mu 4,15718,133,1.24 [1.03-1.50],0.0254115493707454
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUCA2A,Guanylin,18485,160,1.58 [1.10-2.26],0.0127994232775443
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUSB,Beta-glucuronidase,18679,162,1.60 [1.30-1.97],9.401598055349091e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GZMH,Granzyme H,18206,158,1.23 [1.05-1.43],0.0088995465309772
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAO1,Hydroxyacid oxidase 1,18723,163,1.12 [1.01-1.25],0.0375925546445122
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAVCR1,Hepatitis A virus cellular receptor 1,18690,162,2.03 [1.72-2.41],2.728521250228997e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAVCR2,Hepatitis A virus cellular receptor 2,18585,160,2.04 [1.42-2.93],0.0001135634360156
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEG1,Protein HEG homolog 1,15945,138,2.50 [1.38-4.54],0.0025949318652188
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEXIM1,Protein HEXIM1,18533,160,1.21 [1.01-1.46],0.0354196089827363
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HGF,Hepatocyte growth factor,18753,162,3.31 [2.45-4.48],8.493627710660283e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HGFAC,Hepatocyte growth factor activator,16138,136,0.51 [0.36-0.72],0.0001219525276617
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HIP1R,Huntingtin-interacting protein 1-related protein,16212,141,1.57 [1.18-2.08],0.0018377736269271
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",18487,158,1.73 [1.20-2.49],0.0034216330239193
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",18533,160,2.61 [1.77-3.84],1.0862276344805175e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",15876,134,1.66 [1.22-2.26],0.0012153014945735
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",15718,133,1.54 [1.12-2.11],0.008433499477632
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMOX2,Heme oxygenase 2,18150,155,1.55 [1.19-2.01],0.0010435871477686
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,18152,157,1.27 [1.05-1.52],0.0128141185591294
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HPGDS,Hematopoietic prostaglandin D synthase,18156,158,0.50 [0.34-0.74],0.0004890841142584
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HRG,Histidine-rich glycoprotein,16208,136,0.61 [0.39-0.96],0.0327395641160178
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,15876,134,1.71 [1.23-2.37],0.0013896829543805
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPB6,Heat shock protein beta-6,18723,163,1.75 [1.27-2.43],0.0007070953017445
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,18451,159,2.88 [1.98-4.18],2.7385002310529446e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HTRA2,"Serine protease HTRA2, mitochondrial",18648,157,1.33 [1.05-1.68],0.0160880242751093
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HYAL1,Hyaluronidase-1,18494,161,3.87 [2.31-6.46],2.44474178037878e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM1,Intercellular adhesion molecule 1,18505,160,2.85 [1.91-4.23],2.41550220272354e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM2,Intercellular adhesion molecule 2,18801,163,2.10 [1.35-3.27],0.0010710807270494
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM3,Intercellular adhesion molecule 3,18801,163,2.19 [1.34-3.56],0.0016415108533014
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM5,Intercellular adhesion molecule 5,18584,161,1.88 [1.38-2.55],5.419858901332877e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IDS,Iduronate 2-sulfatase,18753,162,0.19 [0.05-0.70],0.0123931478516567
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IDUA,Alpha-L-iduronidase,18723,163,1.64 [1.20-2.24],0.0018853290159363
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,15787,134,2.69 [1.92-3.76],9.841486599596327e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNG,Interferon gamma,18225,158,1.16 [1.02-1.32],0.0290395510856442
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNGR1,Interferon gamma receptor 1,18660,162,2.50 [1.34-4.65],0.0039550480552137
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNGR2,Interferon gamma receptor 2,18398,157,1.46 [1.13-1.90],0.0043093049230985
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGF1R,Insulin-like growth factor 1 receptor,18490,159,2.98 [1.71-5.19],0.0001166035965829
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGF2R,Cation-independent mannose-6-phosphate receptor,18585,160,2.46 [1.35-4.48],0.0033446534458876
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP1,Insulin-like growth factor-binding protein 1,18772,163,1.26 [1.12-1.42],9.693699575261958e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP2,Insulin-like growth factor-binding protein 2,18781,163,1.76 [1.39-2.22],2.818112662111276e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP3,Insulin-like growth factor-binding protein 3,18671,161,0.29 [0.21-0.40],4.259189031723861e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP4,Insulin-like growth factor-binding protein 4,18342,158,1.83 [1.45-2.32],4.60410369228008e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP6,Insulin-like growth factor-binding protein 6,18507,161,1.84 [1.31-2.59],0.0004520025043974
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP7,Insulin-like growth factor-binding protein 7,18801,163,2.78 [2.09-3.72],3.613579270244429e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBPL1,Insulin-like growth factor-binding protein-like 1,18584,161,2.68 [1.91-3.77],1.1504594966265011e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGLC2,Immunoglobulin lambda constant 2,16270,137,2.42 [1.75-3.36],1.1743482113924421e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF3,Immunoglobulin superfamily member 3,18490,159,1.99 [1.52-2.61],5.603659810975005e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF8,Immunoglobulin superfamily member 8,18584,161,1.89 [1.26-2.83],0.0020542049552525
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF9,Protein turtle homolog A,16274,138,1.28 [1.06-1.55],0.008957293194851
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL10RB,Interleukin-10 receptor subunit beta,18660,162,3.07 [2.12-4.45],2.866057785485076e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL12RB1,Interleukin-12 receptor subunit beta-1,18225,158,1.53 [1.08-2.18],0.0181079673026567
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL15,Interleukin-15,18533,160,2.48 [1.66-3.69],8.074211935858238e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL15RA,Interleukin-15 receptor subunit alpha,18225,158,1.69 [1.12-2.53],0.0118110035674243
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17A,Interleukin-17A,18196,158,1.53 [1.16-2.01],0.0026574020369849
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17C,Interleukin-17C,18225,158,1.36 [1.15-1.62],0.0003961143822419
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17RB,Interleukin-17 receptor B,18307,159,0.66 [0.50-0.87],0.002877094656655
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18,Interleukin-18,18522,161,1.84 [1.38-2.44],3.074794204181252e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18BP,Interleukin-18-binding protein,18671,161,2.75 [1.89-4.00],1.127681986363233e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18R1,Interleukin-18 receptor 1,18753,162,1.93 [1.29-2.90],0.0013592014748417
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL19,Interleukin-19,18114,158,1.85 [1.59-2.15],2.7474417107974414e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1B,Interleukin-1 beta,18141,157,1.30 [1.03-1.63],0.024746714266676
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1R1,Interleukin-1 receptor type 1,18558,160,3.23 [1.83-5.67],4.747556604201737e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RAP,Interleukin-1 receptor accessory protein,18585,160,0.39 [0.28-0.55],7.46772405599966e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RL1,Interleukin-1 receptor-like 1,18745,163,2.26 [1.70-2.99],1.3829251327463956e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RL2,Interleukin-1 receptor-like 2,18225,158,0.26 [0.19-0.37],5.3211782583201626e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RN,Interleukin-1 receptor antagonist protein,18538,162,1.33 [1.06-1.65],0.0128068205231879
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL22,Interleukin-22,16206,140,1.73 [1.44-2.08],3.6233036953385837e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL2RA,Interleukin-2 receptor subunit alpha,18417,160,2.50 [1.87-3.34],7.266908794885804e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL32,Interleukin-32,18533,160,1.58 [1.18-2.10],0.001873214384615
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL36G,Interleukin-36 gamma,15721,137,1.30 [1.07-1.58],0.0091748488900766
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL3RA,Interleukin-3 receptor subunit alpha,18225,158,1.82 [1.20-2.77],0.0052145782952172
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL4R,Interleukin-4 receptor subunit alpha,18533,160,2.21 [1.62-3.01],4.429903041245586e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL6,Interleukin-6,18490,159,1.67 [1.49-1.87],3.6310319321171137e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL6ST,Interleukin-6 receptor subunit beta,18584,161,4.16 [1.89-9.16],0.0003966806620316
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,18114,154,1.27 [1.01-1.61],0.0403294675790493
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IMMT,MICOS complex subunit MIC60,16206,140,1.64 [1.23-2.18],0.0007675316402271
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INHBB,Inhibin beta B chain,15945,138,1.76 [1.35-2.29],2.412489640283841e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSL4,Early placenta insulin-like peptide,16206,140,1.33 [1.02-1.75],0.037825960997284
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSL5,Insulin-like peptide INSL5,16196,139,1.26 [1.08-1.47],0.0025928715377758
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSR,Insulin receptor,15792,137,3.51 [1.37-8.96],0.0087911608569296
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",18206,158,1.25 [1.07-1.46],0.0046339264488108
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA11,Integrin alpha-11,18533,160,0.57 [0.39-0.85],0.005466630529161
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA2,Integrin alpha-2,15945,138,0.53 [0.33-0.84],0.0064561523217608
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA5,Integrin alpha-5,18585,160,2.21 [1.28-3.83],0.0046419090279886
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAM,Integrin alpha-M,18585,160,0.58 [0.37-0.93],0.0222073252146742
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAV,Integrin alpha-V,18723,163,0.23 [0.11-0.50],0.0002095350971286
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB1BP2,Integrin beta-1-binding protein 2,18206,158,1.16 [1.02-1.33],0.0287116525351755
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB2,Integrin beta-2,18463,162,0.56 [0.34-0.92],0.0220578371098981
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGBL1,Integrin beta-like protein 1,16282,139,2.24 [1.62-3.11],1.3283799299896898e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,18671,161,1.58 [1.10-2.28],0.014146769963055
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",18150,155,1.36 [1.04-1.79],0.0257633069827458
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JAM2,Junctional adhesion molecule B,18723,162,1.87 [1.19-2.95],0.0069319979238656
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JAM3,Junctional adhesion molecule C,15945,138,1.49 [1.10-2.04],0.0109301544942202
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JCHAIN,Immunoglobulin J chain,18225,158,1.45 [1.17-1.81],0.000832811508329
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIF1C,Kinesin-like protein KIF1C,15718,133,1.63 [1.15-2.32],0.0064051239108216
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,16206,140,1.25 [1.04-1.49],0.0170261157340265
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,18156,158,1.25 [1.05-1.50],0.0135645514444901
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,15698,138,1.18 [1.01-1.38],0.0327720768229334
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIT,Mast/stem cell growth factor receptor Kit,18634,161,0.42 [0.26-0.67],0.0002453440379917
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KITLG,Kit ligand,18584,161,0.52 [0.37-0.73],0.0001728248567712
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK10,Kallikrein-10,18597,156,1.88 [1.42-2.50],1.370195576608423e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK11,Kallikrein-11,18478,156,2.29 [1.76-2.98],6.62636014565334e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK14,Kallikrein-14,18723,163,1.45 [1.10-1.91],0.0087908254725761
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK4,Kallikrein-4,18723,163,1.65 [1.37-1.98],1.3820680235226145e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK8,Kallikrein-8,17978,152,2.03 [1.42-2.88],8.595616714213031e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLKB1,Plasma kallikrein,15946,135,0.17 [0.09-0.31],4.940440022729664e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLRD1,Natural killer cells antigen CD94,18753,162,1.54 [1.14-2.07],0.0044292494688206
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLRF1,Killer cell lectin-like receptor subfamily F member 1,15792,137,1.40 [1.03-1.90],0.0328477651425639
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT18,"Keratin, type I cytoskeletal 18",18490,159,1.29 [1.11-1.50],0.0009767728988249
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT6C,"Keratin, type II cytoskeletal 6C",15718,133,1.81 [1.31-2.49],0.0003184393773569
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT8,"Keratin, type II cytoskeletal 8",15723,135,1.28 [1.10-1.50],0.0014305780195343
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,18581,162,2.45 [1.86-3.24],2.7165404449945757e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMA4,Laminin subunit alpha-4,18660,162,2.17 [1.47-3.22],0.0001125461912326
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMP1,Lysosome-associated membrane glycoprotein 1,15801,137,1.62 [1.14-2.29],0.0067285045785174
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMP3,Lysosome-associated membrane glycoprotein 3,18722,162,1.79 [1.40-2.31],4.715134565810966e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAYN,Layilin,18369,157,2.01 [1.44-2.80],3.950312022421797e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LBP,Lipopolysaccharide-binding protein,18671,161,1.86 [1.48-2.35],1.266639402383334e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LBR,Delta(14)-sterol reductase LBR,18723,162,1.37 [1.14-1.63],0.0005626953235576
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCAT,Phosphatidylcholine-sterol acyltransferase,16290,140,0.24 [0.13-0.46],1.2526895766826235e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCN2,Neutrophil gelatinase-associated lipocalin,18034,153,1.89 [1.42-2.51],1.1688222541238511e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LDLR,Low-density lipoprotein receptor,18619,161,0.57 [0.43-0.75],6.880441368009113e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEG1,Protein LEG1 homolog,15439,133,1.48 [1.18-1.85],0.0005522660709808
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LETM1,Mitochondrial proton/calcium exchanger protein,16246,139,1.63 [1.25-2.13],0.00035348819264
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS1,Galectin-1,18584,161,1.63 [1.13-2.35],0.0087708017655898
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS3BP,Galectin-3-binding protein,16302,138,2.86 [1.94-4.22],1.0120494911564633e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS4,Galectin-4,18581,162,2.00 [1.60-2.49],7.14398369013708e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS7_LGALS7B,Galectin-7,18496,160,2.00 [1.54-2.59],1.5342529797243613e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS9,Galectin-9,18573,162,2.66 [1.80-3.92],7.998346607170662e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGMN,Legumain,18660,162,2.73 [1.88-3.95],1.264343732754352e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LIFR,Leukemia inhibitory factor receptor,18533,160,2.57 [1.49-4.44],0.0007091677965238
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,18550,161,3.00 [1.96-4.58],4.01888223908768e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,16274,138,1.32 [1.05-1.67],0.0165493529220051
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,18225,158,1.59 [1.19-2.13],0.0018926217815049
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMNB2,Lamin-B2,16250,141,2.03 [1.27-3.25],0.003100934045619
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMOD1,Leiomodin-1,16246,139,1.48 [1.02-2.13],0.036462315585492
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LONP1,"Lon protease homolog, mitochondrial",15876,134,1.43 [1.19-1.72],0.0001824890147772
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPO,Lactoperoxidase,17932,154,1.63 [1.30-2.04],2.3066605497708626e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRG1,Leucine-rich alpha-2-glycoprotein,16302,138,2.43 [1.39-4.24],0.0018536064315847
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,18660,162,1.49 [1.01-2.20],0.0428507448214531
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRP1,Prolow-density lipoprotein receptor-related protein 1,18490,159,1.82 [1.11-3.01],0.0185784401131026
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRP11,Low-density lipoprotein receptor-related protein 11,18584,161,1.56 [1.08-2.24],0.0175561971117774
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,18723,162,1.34 [1.10-1.64],0.0037362421037745
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRC25,Leucine-rich repeat-containing protein 25,18490,159,1.57 [1.14-2.16],0.0054125275301233
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,16206,140,1.41 [1.01-1.96],0.0411286207727616
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRN1,Leucine-rich repeat neuronal protein 1,18225,158,0.50 [0.36-0.71],0.0001082986661239
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTB,Lymphotoxin-beta,16206,140,0.51 [0.29-0.90],0.0192616941393356
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBP2,Latent-transforming growth factor beta-binding protein 2,18801,163,2.22 [1.52-3.24],3.226555719960091e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBP3,Latent-transforming growth factor beta-binding protein 3,18156,158,1.44 [1.16-1.77],0.0007340483066197
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBR,Tumor necrosis factor receptor superfamily member 3,18499,162,3.38 [2.31-4.94],3.5400514902831973e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY6D,Lymphocyte antigen 6D,18484,161,1.71 [1.28-2.29],0.0003307982662936
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY9,T-lymphocyte surface antigen Ly-9,18335,158,2.24 [1.44-3.49],0.0003389979291364
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY96,Lymphocyte antigen 96,18398,157,3.32 [2.44-4.52],2.3778490516124574e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYPD3,Ly6/PLAUR domain-containing protein 3,18499,157,1.51 [1.01-2.27],0.0456478710528007
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYPD8,Ly6/PLAUR domain-containing protein 8,18156,158,1.65 [1.32-2.06],1.229698119224587e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,16302,138,2.41 [1.07-5.42],0.0328873606407715
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",M6PR,Cation-dependent mannose-6-phosphate receptor,15876,134,1.65 [1.19-2.30],0.0028149889167265
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,18329,156,1.43 [1.14-1.78],0.0016732647034018
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAMDC2,MAM domain-containing protein 2,16274,138,2.01 [1.35-3.00],0.0005855078544211
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MANSC1,MANSC domain-containing protein 1,18648,157,1.86 [1.12-3.07],0.0163013736294573
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,15723,135,1.78 [1.02-3.09],0.0408229872090889
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP2,Microtubule-associated protein 2,16250,141,1.56 [1.15-2.11],0.0039542747065533
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MARCO,Macrophage receptor MARCO,18584,161,2.20 [1.28-3.77],0.0041727105056199
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MATN2,Matrilin-2,18607,162,2.96 [1.90-4.63],1.6865930274442585e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MATN3,Matrilin-3,18368,157,1.90 [1.26-2.86],0.0020643347821661
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAVS,Mitochondrial antiviral-signaling protein,18156,158,1.23 [1.05-1.45],0.0102290730869431
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MBL2,Mannose-binding protein C,16074,136,1.22 [1.04-1.43],0.0167635796665572
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCFD2,Multiple coagulation factor deficiency protein 2,18493,161,1.59 [1.15-2.20],0.0054909717902464
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MDK,Midkine,18606,156,1.72 [1.40-2.10],1.8789968480439082e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",15876,134,1.36 [1.14-1.64],0.0008857278688555
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MENT,Protein MENT,15945,138,0.17 [0.09-0.33],6.958641426921635e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEP1B,Meprin A subunit beta,18584,161,0.68 [0.60-0.76],5.694511341259827e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MERTK,Tyrosine-protein kinase Mer,18753,162,2.13 [1.25-3.61],0.0052885978881073
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MET,Hepatocyte growth factor receptor,18619,159,0.31 [0.16-0.62],0.0008664946643213
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",18533,160,1.27 [1.06-1.51],0.0080278049258604
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFAP4,Microfibril-associated glycoprotein 4,15945,138,1.99 [1.23-3.23],0.0051307927736247
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MICALL2,MICAL-like protein 2,15834,134,1.29 [1.05-1.58],0.0140601653960132
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MILR1,Allergin-1,18225,158,1.56 [1.21-2.01],0.0006911471471087
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MME,Neprilysin,18490,159,1.23 [1.04-1.45],0.0158291410519723
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP1,Interstitial collagenase,17879,153,1.30 [1.09-1.54],0.0033175722271255
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP10,Stromelysin-2,18536,161,1.55 [1.24-1.93],9.357581601477374e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP12,Macrophage metalloelastase,18575,161,1.94 [1.56-2.41],2.65306006140526e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP3,Stromelysin-1,18585,160,1.72 [1.40-2.11],2.178654023543213e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP7,Matrilysin,18175,158,2.17 [1.60-2.94],5.018550403145025e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP8,Neutrophil collagenase,18691,161,1.53 [1.28-1.83],2.6064677455194075e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP9,Matrix metalloproteinase-9,18550,160,1.61 [1.27-2.05],7.67524346157587e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",15718,133,1.48 [1.08-2.02],0.0147396941881415
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MPO,Myeloperoxidase,18585,160,1.39 [1.06-1.84],0.0177554536992892
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRC1,Macrophage mannose receptor 1,16290,140,4.45 [2.80-7.08],2.9298420257974715e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRI1,Methylthioribose-1-phosphate isomerase,15834,134,0.69 [0.54-0.87],0.0017337372534004
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPL46,"39S ribosomal protein L46, mitochondrial",18150,155,1.83 [1.23-2.72],0.0027755602875535
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",16246,139,1.39 [1.15-1.67],0.0005247346625793
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSLN,Mesothelin,18458,159,1.49 [1.21-1.83],0.0001910175055694
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSLNL,Mesothelin-like protein,15834,134,1.41 [1.01-1.99],0.046723270750202
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSR1,Macrophage scavenger receptor types I and II,18723,162,2.21 [1.65-2.96],8.748583926762615e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",16250,141,1.62 [1.06-2.49],0.0267266785587701
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTIF3,"Translation initiation factor IF-3, mitochondrial",16196,139,1.24 [1.03-1.50],0.0252996023241572
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTUS1,Microtubule-associated tumor suppressor 1,15972,137,1.45 [1.12-1.88],0.0050020629332441
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MUC13,Mucin-13,18150,155,1.43 [1.11-1.85],0.0056087872399725
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MVK,Mevalonate kinase,18225,158,1.46 [1.24-1.73],6.829938585567486e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MZB1,Marginal zone B- and B1-cell-specific protein,18638,162,2.41 [1.93-3.01],1.1343298375483375e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAAA,N-acylethanolamine-hydrolyzing acid amidase,18309,153,0.74 [0.57-0.96],0.0237389765289026
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NBL1,Neuroblastoma suppressor of tumorigenicity 1,18648,157,3.01 [1.90-4.79],3.060569364896344e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCAN,Neurocan core protein,18723,162,0.54 [0.39-0.76],0.0003439467396731
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCR1,Natural cytotoxicity triggering receptor 1,18505,160,1.45 [1.01-2.09],0.0450649383435474
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,16196,139,2.87 [1.96-4.21],6.108703373940036e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",18156,158,1.27 [1.10-1.47],0.0009073325236496
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECTIN2,Nectin-2,18550,161,2.77 [1.90-4.05],1.2308683376322348e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECTIN4,Nectin-4,18648,157,2.28 [1.66-3.13],3.6957615524107387e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEFL,Neurofilament light polypeptide,18097,154,1.43 [1.07-1.92],0.014966067773859
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NELL1,Protein kinase C-binding protein NELL1,18648,157,0.70 [0.50-0.97],0.029680095534334
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFASC,Neurofascin,18753,162,2.80 [1.81-4.35],3.986766901155506e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFAT5,Nuclear factor of activated T-cells 5,15792,137,1.26 [1.06-1.51],0.0107467083183484
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",18225,158,1.36 [1.10-1.67],0.0039392086204596
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFKB1,Nuclear factor NF-kappa-B p105 subunit,15718,133,1.30 [1.03-1.65],0.0291302208735256
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",16196,139,1.26 [1.07-1.48],0.006044013917362
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NGRN,Neugrin,16250,141,1.88 [1.02-3.47],0.0429254751894104
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NHLRC3,NHL repeat-containing protein 3,15545,136,4.03 [2.43-6.67],6.678287218349827e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NID1,Nidogen-1,18604,161,1.77 [1.25-2.51],0.0014155349707244
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NINJ1,Ninjurin-1,18156,158,1.33 [1.06-1.66],0.0120388318252223
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NME3,Nucleoside diphosphate kinase 3,18607,162,2.51 [1.61-3.90],4.430831345778336e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NMI,N-myc-interactor,16156,140,1.39 [1.12-1.74],0.0035264796917189
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOS1,"Nitric oxide synthase, brain",18150,155,1.36 [1.05-1.75],0.0207754592289991
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOS3,"Nitric oxide synthase, endothelial",18150,155,1.68 [1.40-2.01],1.5265503067162986e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOTCH3,Neurogenic locus notch homolog protein 3,18801,163,1.76 [1.20-2.57],0.0037465306981165
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPC2,NPC intracellular cholesterol transporter 2,15997,138,2.44 [1.77-3.36],4.596365890715885e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPDC1,Neural proliferation differentiation and control protein 1,18584,161,2.12 [1.55-2.89],2.034238405357766e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPPB,Natriuretic peptides B,18206,158,1.24 [1.12-1.37],2.7578496699696576e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPPC,C-type natriuretic peptide,18533,160,1.59 [1.29-1.97],1.8308528808120097e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTX2,Neuronal pentraxin-2,16282,139,2.49 [1.64-3.78],1.916801450455102e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTXR,Neuronal pentraxin receptor,18584,161,0.43 [0.27-0.68],0.000332238008598
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRP1,Neuropilin-1,18698,161,2.47 [1.53-4.00],0.0002294607044374
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5C1A,Cytosolic 5'-nucleotidase 1A,16250,141,2.23 [1.57-3.17],7.17303586805514e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTRK2,BDNF/NT-3 growth factors receptor,18584,161,0.49 [0.28-0.85],0.011067310843891
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTproBNP,N-terminal prohormone of brain natriuretic peptide,18584,161,1.38 [1.25-1.53],4.3139961012720575e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUCB2,Nucleobindin-2,18688,163,2.02 [1.41-2.90],0.0001315036871267
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT16,U8 snoRNA-decapping enzyme,16162,138,1.24 [1.02-1.50],0.0320245231083984
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT5,ADP-sugar pyrophosphatase,18585,160,1.40 [1.07-1.82],0.0135108659429321
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OBP2B,Odorant-binding protein 2b,18342,157,1.26 [1.04-1.53],0.0207189281636865
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OCLN,Occludin,16246,139,2.41 [1.85-3.14],7.325535243662782e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ODAM,Odontogenic ameloblast-associated protein,18124,154,0.71 [0.53-0.95],0.0220083374114647
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OGN,Mimecan,18585,160,1.46 [1.09-1.97],0.0121045978974832
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OLFM4,Olfactomedin-4,15345,135,1.16 [1.00-1.34],0.0449713767634374
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OLR1,Oxidized low-density lipoprotein receptor 1,18399,158,1.30 [1.05-1.61],0.0173178703419696
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OMG,Oligodendrocyte-myelin glycoprotein,18490,159,0.71 [0.58-0.88],0.0018292978509342
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ORM1,Alpha-1-acid glycoprotein 1,16244,138,2.70 [1.26-5.80],0.0109052633094797
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSCAR,Osteoclast-associated immunoglobulin-like receptor,18607,162,2.90 [1.92-4.38],4.141906495870902e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSM,Oncostatin-M,18450,158,1.43 [1.17-1.75],0.0004064238347511
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSMR,Oncostatin-M-specific receptor subunit beta,18698,161,2.55 [1.33-4.88],0.0048204033645308
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",15876,134,1.30 [1.03-1.64],0.0268746435741137
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OXT,Oxytocin-neurophysin 1,18723,162,1.17 [1.06-1.28],0.0017742407089645
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAEP,Glycodelin,18398,157,1.27 [1.12-1.45],0.0002493082238693
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,18206,158,1.35 [1.07-1.71],0.0118874354185994
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PALM2,Paralemmin-2,16250,141,2.20 [1.56-3.11],7.702870248344619e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAMR1,Inactive serine protease PAMR1,18585,160,0.51 [0.31-0.85],0.0102468668227998
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH12,Protocadherin-12,16246,139,2.04 [1.08-3.86],0.0276673909753375
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH9,Protocadherin-9,16196,139,0.60 [0.37-0.96],0.0319801602223655
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDHB15,Protocadherin beta-15,16206,140,2.12 [1.49-3.04],3.451431211866237e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCSK9,Proprotein convertase subtilisin/kexin type 9,18801,163,1.45 [1.03-2.06],0.0357394968412589
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDCD1LG2,Programmed cell death 1 ligand 2,18490,159,1.90 [1.24-2.91],0.00313303970836
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFRB,Platelet-derived growth factor receptor beta,18801,163,0.58 [0.39-0.86],0.0075046462807701
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDZD2,PDZ domain-containing protein 2,15718,133,1.45 [1.14-1.86],0.0028007872994011
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,15792,137,1.72 [1.25-2.37],0.0007826103700467
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PECAM1,Platelet endothelial cell adhesion molecule,18585,160,1.80 [1.13-2.86],0.0132030701091581
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PER3,Period circadian protein homolog 3,15792,137,1.20 [1.06-1.37],0.0043942740144207
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGA4,Pepsin A-4,16290,140,1.28 [1.05-1.57],0.0168572441998608
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGF,Placenta growth factor,18753,162,3.57 [2.40-5.32],3.963313657026141e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGLYRP1,Peptidoglycan recognition protein 1,18725,163,1.62 [1.22-2.15],0.0008568093130076
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGLYRP4,Peptidoglycan recognition protein 4,15718,133,1.41 [1.13-1.77],0.0023932154149883
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHLDB1,Pleckstrin homology-like domain family B member 1,16196,139,1.86 [1.39-2.48],2.464999800025841e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,18398,157,2.14 [1.30-3.50],0.0025973749276211
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PI3,Elafin,18354,160,1.87 [1.55-2.26],4.903490179814422e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIGR,Polymeric immunoglobulin receptor,18345,158,3.60 [2.59-5.02],3.441033240067675e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,18585,160,2.26 [1.52-3.36],6.0432191690574445e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PILRA,Paired immunoglobulin-like type 2 receptor alpha,18585,160,2.82 [2.03-3.92],7.710349037579013e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PILRB,Paired immunoglobulin-like type 2 receptor beta,18584,161,1.99 [1.52-2.60],4.95363109209434e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PKD1,Polycystin-1,16274,138,2.98 [1.62-5.48],0.0004353448240827
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PKD2,Polycystin-2,15718,133,1.39 [1.06-1.82],0.0165172281370627
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G15,Phospholipase A2 group XV,18648,157,4.16 [2.60-6.64],2.413503143989319e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G1B,Phospholipase A2,18778,163,0.58 [0.45-0.76],5.791582621222248e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G2A,"Phospholipase A2, membrane associated",18528,161,1.48 [1.22-1.79],6.489884492195864e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G7,Platelet-activating factor acetylhydrolase,18585,160,0.55 [0.37-0.84],0.0050106762706591
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAT,Tissue-type plasminogen activator,18745,163,2.06 [1.57-2.70],1.633695608500158e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAU,Urokinase-type plasminogen activator,18585,160,1.74 [1.22-2.48],0.0023248186879352
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAUR,Urokinase plasminogen activator surface receptor,18464,162,5.45 [3.65-8.16],1.38519563507715e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLIN3,Perilipin-3,18584,161,1.57 [1.14-2.15],0.0054426601295081
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXDC2,Plexin domain-containing protein 2,16250,141,1.86 [1.09-3.16],0.022283055510303
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXNB2,Plexin-B2,18701,163,2.85 [1.67-4.86],0.0001179758266378
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNLIP,Pancreatic triacylglycerol lipase,16290,140,0.72 [0.57-0.91],0.0060862985353665
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNLIPRP1,Inactive pancreatic lipase-related protein 1,16250,141,0.77 [0.63-0.93],0.007291517452686
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POF1B,Protein POF1B,15792,137,1.49 [1.08-2.06],0.0147514591769013
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",18490,159,1.59 [1.14-2.22],0.0057537435280377
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PON1,Serum paraoxonase/arylesterase 1,16290,140,0.39 [0.25-0.63],8.205299012325763e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PON2,Serum paraoxonase/arylesterase 2,18206,158,1.79 [1.20-2.66],0.0043640116289417
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PON3,Serum paraoxonase/lactonase 3,18660,162,0.47 [0.35-0.64],9.021306783198688e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",16282,139,1.31 [1.04-1.65],0.022215360813431
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,16246,139,1.78 [1.29-2.45],0.0003905865181179
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP3R1,Calcineurin subunit B type 1,18398,157,1.70 [1.20-2.40],0.0028806270493597
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRAP1,Proline-rich acidic protein 1,16282,139,2.55 [1.68-3.87],1.2122443564497742e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRCP,Lysosomal Pro-X carboxypeptidase,18712,162,1.71 [1.16-2.52],0.0063188465643688
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",18225,158,1.37 [1.12-1.66],0.001706409528268
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRG2,Bone marrow proteoglycan,16282,139,1.86 [1.38-2.50],4.266201394534287e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRL,Prolactin,18723,162,1.24 [1.03-1.50],0.0238883106067589
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRND,Prion-like protein doppel,16250,141,1.54 [1.15-2.05],0.003560825334202
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PROC,Vitamin K-dependent protein C,18634,161,0.31 [0.18-0.52],9.635439945999524e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PROK1,Prokineticin-1,18533,160,1.36 [1.13-1.62],0.0008059023274432
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS22,Brain-specific serine protease 4,15792,137,2.18 [1.64-2.89],7.60250359451687e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS8,Prostasin,18503,162,2.84 [2.13-3.80],1.711398087304702e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRTG,Protogenin,18723,163,2.69 [1.55-4.68],0.0004410278059833
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRTN3,Myeloblastin,18090,156,1.48 [1.17-1.88],0.0013109206522134
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSAP,Prosaposin,16114,139,2.81 [1.94-4.08],4.7024931486147526e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSPN,Persephin,18533,160,1.25 [1.12-1.40],9.037551156015954e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTGDS,Prostaglandin-H2 D-isomerase,18437,159,2.10 [1.48-2.98],2.9849751857540543e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTGES2,Prostaglandin E synthase 2,15668,133,1.41 [1.03-1.95],0.0326935511166396
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTGR1,Prostaglandin reductase 1,16274,138,1.30 [1.08-1.57],0.0055296389045313
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTK7,Inactive tyrosine-protein kinase 7,18150,155,2.07 [1.43-2.98],0.00010386756062
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTN,Pleiotrophin,18206,158,1.77 [1.37-2.29],1.259752668365918e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,18398,157,1.28 [1.07-1.53],0.007654547415876
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRH,Receptor-type tyrosine-protein phosphatase H,16196,139,1.40 [1.01-1.94],0.0433080069725463
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,16196,139,3.04 [1.78-5.18],4.359656129094189e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRS,Receptor-type tyrosine-protein phosphatase S,18801,163,0.50 [0.29-0.87],0.0150580112055647
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTX3,Pentraxin-related protein PTX3,18533,160,1.48 [1.07-2.05],0.0185342099323681
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PVR,Poliovirus receptor,18723,162,2.40 [1.74-3.31],1.123420803934898e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PZP,Pregnancy zone protein,16302,138,0.48 [0.35-0.66],3.54222275751806e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",QPCT,Glutaminyl-peptide cyclotransferase,18626,162,2.25 [1.42-3.57],0.0005796451304923
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",QSOX1,Sulfhydryl oxidase 1,15976,136,1.47 [1.10-1.96],0.0085046704676236
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB6A,Ras-related protein Rab-6A,18533,160,0.63 [0.47-0.85],0.0020499660477127
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB6B,Ras-related protein Rab-6B,18150,155,1.42 [1.12-1.81],0.0036746199493397
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RABEPK,Rab9 effector protein with kelch motifs,18156,158,1.39 [1.12-1.72],0.0028887062142115
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RALB,Ras-related protein Ral-B,15792,137,2.60 [1.53-4.43],0.0004276234594581
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RARRES1,Retinoic acid receptor responder protein 1,18156,158,1.50 [1.06-2.13],0.0223384511351724
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RARRES2,Retinoic acid receptor responder protein 2,18698,161,1.60 [1.24-2.08],0.0003371709860231
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RASSF2,Ras association domain-containing protein 2,18156,158,1.24 [1.01-1.53],0.0427716302850231
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBFOX3,RNA binding protein fox-1 homolog 3,16246,139,2.09 [1.60-2.73],6.122435333440214e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP2,Retinol-binding protein 2,18490,159,1.41 [1.18-1.68],0.000144711077099
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP5,Retinol-binding protein 5,18490,159,1.33 [1.05-1.68],0.0166350259353974
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBPMS2,RNA-binding protein with multiple splicing 2,15876,134,1.19 [1.01-1.41],0.0432825056747611
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RCC1,Regulator of chromosome condensation,16206,140,1.34 [1.03-1.75],0.0294004110497223
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REEP4,Receptor expression-enhancing protein 4,16246,139,1.41 [1.10-1.81],0.0061520394165452
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG4,Regenerating islet-derived protein 4,18607,162,1.34 [1.04-1.73],0.0247485542036559
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RELB,Transcription factor RelB,15792,137,1.48 [1.13-1.94],0.0040846488225986
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RELT,Tumor necrosis factor receptor superfamily member 19L,18585,160,2.66 [1.87-3.79],6.393394582438704e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REN,Renin,18584,161,1.53 [1.34-1.74],3.81817022878236e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RETN,Resistin,18539,159,1.71 [1.29-2.27],0.0001778314196765
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGMB,RGM domain family member B,18723,162,2.05 [1.29-3.27],0.0024428091806053
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE1,Ribonuclease pancreatic,16290,140,2.56 [1.71-3.84],5.4449607825522585e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE10,Inactive ribonuclease-like protein 10,15876,134,1.53 [1.13-2.08],0.0063220535653173
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE4,Ribonuclease 4,15752,133,2.02 [1.26-3.25],0.0035272100549656
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE6,Ribonuclease K6,16178,140,2.17 [1.65-2.84],2.7759813981656653e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASET2,Ribonuclease T2,18734,162,3.81 [2.54-5.71],1.0811583143967448e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF149,E3 ubiquitin-protein ligase RNF149,15876,134,3.02 [2.00-4.57],1.555696602878559e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ROBO1,Roundabout homolog 1,18607,162,1.92 [1.14-3.25],0.0146578726169503
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RP2,Protein XRP2,18490,159,1.55 [1.13-2.13],0.0062926097722874
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RPGR,X-linked retinitis pigmentosa GTPase regulator,15834,134,0.58 [0.36-0.95],0.0307301704800588
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RSPO1,R-spondin-1,18398,157,2.18 [1.53-3.09],1.3414371706676836e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RSPO3,R-spondin-3,18723,163,1.89 [1.24-2.89],0.0032202683522386
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A11,Protein S100-A11,18439,159,1.34 [1.04-1.74],0.0248499783048506
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100G,Protein S100-G,16246,139,1.49 [1.10-2.01],0.0097952249570905
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100P,Protein S100-P,18206,158,1.29 [1.01-1.63],0.0376357025336656
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SBSN,Suprabasin,16246,139,1.79 [1.12-2.87],0.014456588462674
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCAMP3,Secretory carrier-associated membrane protein 3,18490,159,1.27 [1.07-1.50],0.0053192205186026
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARB2,Lysosome membrane protein 2,18057,153,2.38 [1.72-3.29],1.639734840476169e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARF1,Scavenger receptor class F member 1,18801,163,1.83 [1.33-2.51],0.0001930489567253
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARF2,Scavenger receptor class F member 2,18723,162,2.38 [1.53-3.70],0.0001239036450152
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB1A1,Uteroglobin,18589,161,0.77 [0.61-0.97],0.0241150380651329
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCLY,Selenocysteine lyase,18660,162,1.59 [1.22-2.08],0.0006847699161598
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCP2,Non-specific lipid-transfer protein,18156,158,1.34 [1.14-1.57],0.0003196291549365
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCPEP1,Retinoid-inducible serine carboxypeptidase,15807,134,2.12 [1.55-2.90],2.5927275504386622e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCRG1,Scrapie-responsive protein 1,16274,138,1.93 [1.19-3.13],0.0073963472975563
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCT,Secretin,15834,134,0.50 [0.35-0.72],0.0001771660279203
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDC1,Syndecan-1,18584,161,1.96 [1.48-2.59],2.7174808107225944e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDC4,Syndecan-4,18584,161,0.65 [0.49-0.85],0.0018342406972995
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDHB,Succinate dehydrogenase,16196,139,1.30 [1.03-1.63],0.0254507558906704
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEL1L,Protein sel-1 homolog 1,15876,134,2.19 [1.62-2.97],4.103773239338969e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELE,E-selectin,18801,163,1.41 [1.06-1.86],0.0167550540710593
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELENOP,Selenoprotein P,16302,138,0.23 [0.11-0.47],4.810880357066104e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELP,P-selectin,18671,161,1.39 [1.09-1.79],0.0092651870493943
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN3,Neuronal-specific septin-3,16246,139,1.41 [1.16-1.72],0.0006015618655186
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN8,Septin-8,16227,141,2.16 [1.50-3.12],3.782480825114413e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA12,Serpin A12,18028,155,0.77 [0.64-0.92],0.0045287544733579
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA3,Alpha-1-antichymotrypsin,16235,137,3.15 [1.26-7.86],0.0140900842496986
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA4,Kallistatin,16010,137,0.15 [0.08-0.28],3.3450192205930355e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA5,Plasma serine protease inhibitor,16062,137,0.29 [0.16-0.53],6.778768369502374e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA6,Corticosteroid-binding globulin,16302,138,0.38 [0.15-1.00],0.0489175542114864
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB6,Serpin B6,18664,162,1.34 [1.05-1.71],0.0202861587966982
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB8,Serpin B8,18753,162,1.38 [1.15-1.66],0.0006652827278527
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINE1,Plasminogen activator inhibitor 1,18801,163,1.34 [1.08-1.67],0.0088862910239297
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINF1,Pigment epithelium-derived factor,16036,136,2.10 [1.16-3.81],0.0140414485296162
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFRP1,Secreted frizzled-related protein 1,18344,157,1.57 [1.20-2.06],0.0011476230276449
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPA1,Pulmonary surfactant-associated protein A1,18156,158,1.39 [1.14-1.69],0.0010740857242242
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPA2,Pulmonary surfactant-associated protein A2,18156,158,1.29 [1.02-1.62],0.0342860090587316
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SGSH,N-sulphoglucosamine sulphohydrolase,15972,135,1.43 [1.08-1.89],0.0127564225476847
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHISA5,Protein shisa-5,16282,139,2.64 [1.87-3.73],3.8131067016545734e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIAE,Sialate O-acetylesterase,18618,156,1.96 [1.45-2.66],1.358593147492978e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC1,Sialoadhesin,18660,162,2.48 [1.84-3.33],1.873819649765301e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC10,Sialic acid-binding Ig-like lectin 10,18533,160,2.01 [1.41-2.85],9.509576478860117e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC5,Sialic acid-binding Ig-like lectin 5,18585,160,1.18 [1.02-1.36],0.0220240586132659
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC7,Sialic acid-binding Ig-like lectin 7,18584,161,1.75 [1.06-2.87],0.0282789852722868
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC8,Sialic acid-binding Ig-like lectin 8,15876,134,1.74 [1.23-2.47],0.0018267750927078
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC9,Sialic acid-binding Ig-like lectin 9,18690,162,1.83 [1.13-2.97],0.0134951472601586
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRPB1,Signal-regulatory protein beta-1,18555,162,1.88 [1.43-2.48],7.434472883789266e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF1,Signaling lymphocytic activation molecule,18225,158,1.61 [1.28-2.04],5.896733129747672e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF6,SLAM family member 6,18156,158,1.63 [1.15-2.32],0.0064938988167853
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF7,SLAM family member 7,18533,160,1.78 [1.44-2.19],7.337038705982738e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF8,SLAM family member 8,18156,158,2.00 [1.54-2.60],2.464387761626153e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC12A2,Solute carrier family 12 member 2,15718,133,1.71 [1.01-2.87],0.043812301730006
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC16A1,Monocarboxylate transporter 1,18150,155,1.38 [1.14-1.67],0.0011702042849136
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC1A4,Neutral amino acid transporter A,15834,134,1.46 [1.14-1.87],0.0025564714438399
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC27A4,Long-chain fatty acid transport protein 4,18150,155,1.33 [1.11-1.60],0.002282113764915
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC34A3,Sodium-dependent phosphate transport protein 2C,15698,138,0.57 [0.36-0.90],0.0157597332643664
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLIT2,Slit homolog 2 protein,18150,155,1.43 [1.13-1.82],0.0034352598685767
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLITRK1,SLIT and NTRK-like protein 1,15792,137,0.57 [0.35-0.93],0.0235871203845195
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLITRK2,SLIT and NTRK-like protein 2,18723,163,0.66 [0.47-0.94],0.0207458045333083
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLK,STE20-like serine/threonine-protein kinase,15972,137,0.73 [0.53-0.99],0.0458776165852753
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLMAP,Sarcolemmal membrane-associated protein,16196,139,1.33 [1.09-1.62],0.0043814410593372
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMOC1,SPARC-related modular calcium-binding protein 1,18723,163,1.85 [1.23-2.77],0.0029929726187329
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMOC2,SPARC-related modular calcium-binding protein 2,18660,162,2.54 [1.88-3.42],8.678081492641852e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPD1,Sphingomyelin phosphodiesterase,18633,160,1.90 [1.48-2.44],4.85052874402005e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMTN,Smoothelin,16226,141,1.31 [1.11-1.55],0.0014139905056919
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",15876,134,1.63 [1.08-2.45],0.0196176798816925
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOD2,"Superoxide dismutase [Mn], mitochondrial",18585,160,1.87 [1.37-2.54],6.490990322917197e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SORCS2,VPS10 domain-containing receptor SorCS2,18156,158,1.55 [1.09-2.21],0.0146728446040317
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPESP1,Sperm equatorial segment protein 1,16274,138,2.44 [1.57-3.80],7.981074800352915e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK1,Serine protease inhibitor Kazal-type 1,18585,160,1.70 [1.31-2.19],5.722361094714776e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK2,Serine protease inhibitor Kazal-type 2,15945,138,2.01 [1.38-2.92],0.0002408371212745
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK4,Serine protease inhibitor Kazal-type 4,18533,160,1.29 [1.06-1.57],0.0109667707269753
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK5,Serine protease inhibitor Kazal-type 5,18585,160,1.51 [1.03-2.21],0.0351512479382306
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK6,Serine protease inhibitor Kazal-type 6,18723,163,1.40 [1.06-1.85],0.0162421208299514
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT1,Kunitz-type protease inhibitor 1,18531,159,2.90 [1.92-4.37],3.7703893862641353e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT2,Kunitz-type protease inhibitor 2,18660,162,1.90 [1.34-2.67],0.000269735217311
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT3,Kunitz-type protease inhibitor 3,16196,139,1.11 [1.05-1.19],0.0005453213229884
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPON1,Spondin-1,18607,162,2.38 [1.71-3.32],3.175575303502391e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPON2,Spondin-2,18496,160,3.03 [2.14-4.28],3.505746422293342e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPP1,Osteopontin,18781,163,1.61 [1.22-2.12],0.0006841343115343
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SRPX,Sushi repeat-containing protein SRPX,16274,138,1.85 [1.19-2.88],0.006498401955828
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,18550,161,0.76 [0.66-0.87],4.207328434279223e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",18801,163,2.81 [1.94-4.05],3.99515647115889e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STC1,Stanniocalcin-1,18723,162,1.61 [1.21-2.15],0.0011324366423821
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX4,Syntaxin-4,18490,159,1.42 [1.17-1.73],0.0003764419829838
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX8,Syntaxin-8,18533,160,1.55 [1.17-2.06],0.0022305389299562
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SULT2A1,Bile salt sulfotransferase,18533,160,1.43 [1.18-1.74],0.0002989039178303
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUOX,"Sulfite oxidase, mitochondrial",16246,139,1.36 [1.08-1.72],0.0096381741942333
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD2,Sushi domain-containing protein 2,18585,160,1.82 [1.19-2.80],0.0057202616695508
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SV2A,Synaptic vesicle glycoprotein 2A,15834,134,1.27 [1.02-1.60],0.0357304175448926
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TACSTD2,Tumor-associated calcium signal transducer 2,16421,136,2.50 [1.68-3.72],5.693908731798916e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAFA5,Chemokine-like protein TAFA-5,18490,159,1.65 [1.17-2.31],0.0040418727902197
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAX1BP1,Tax1-binding protein 1,16250,141,1.32 [1.02-1.70],0.0323906427669796
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBC1D23,TBC1 domain family member 23,18490,159,1.18 [1.00-1.39],0.0454021935013614
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBC1D5,TBC1 domain family member 5,18533,160,1.22 [1.02-1.45],0.0278936959407031
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCN1,Transcobalamin-1,15963,138,2.23 [1.58-3.14],5.3784677304766575e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCN2,Transcobalamin-2,18781,163,1.82 [1.22-2.69],0.0030221536404083
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCTN3,Tectonic-3,16274,138,2.43 [1.39-4.26],0.0018054702653132
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TDRKH,Tudor and KH domain-containing protein,18150,155,1.25 [1.05-1.49],0.0106900547198228
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF1,Trefoil factor 1,18488,159,1.27 [1.09-1.48],0.0026015573747825
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF2,Trefoil factor 2,18629,162,1.70 [1.38-2.09],5.121716095266393e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF3,Trefoil factor 3,18569,159,1.61 [1.27-2.04],9.589333971509652e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFPI2,Tissue factor pathway inhibitor 2,18598,156,1.58 [1.27-1.97],4.394722693065942e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFA,Protransforming growth factor alpha,18533,160,2.01 [1.57-2.58],2.9885806245210954e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFB1,Transforming growth factor beta-1 proprotein,18722,162,2.44 [1.78-3.36],3.8732393418596736e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBR2,TGF-beta receptor type-2,18648,157,2.39 [1.75-3.28],5.2249578815216854e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBR3,Transforming growth factor beta receptor type 3,18801,163,1.68 [1.08-2.59],0.0200373205790223
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGOLN2,Trans-Golgi network integral membrane protein 2,16290,140,2.02 [1.16-3.53],0.0136139543074297
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THBD,Thrombomodulin,18584,161,1.95 [1.26-3.02],0.0028123016009095
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THBS2,Thrombospondin-2,18585,160,2.37 [1.79-3.14],1.9417344860499822e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THBS4,Thrombospondin-4,18604,161,1.46 [1.07-1.97],0.0152382338223338
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THY1,Thy-1 membrane glycoprotein,18723,162,2.01 [1.32-3.08],0.0012329554124315
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",18121,155,1.36 [1.01-1.83],0.0417047852408372
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,18671,161,1.56 [1.16-2.10],0.0034818223280257
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP1,Metalloproteinase inhibitor 1,18389,158,3.32 [2.34-4.72],1.7396689715349543e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP2,Metalloproteinase inhibitor 2,16274,138,1.59 [1.11-2.29],0.0123886672705135
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP3,Metalloproteinase inhibitor 3,18660,162,1.12 [1.02-1.24],0.0240735333014629
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP4,Metalloproteinase inhibitor 4,18585,160,2.16 [1.65-2.82],1.57162932981484e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TINAGL1,Tubulointerstitial nephritis antigen-like,18520,161,2.65 [1.45-4.85],0.0015419004543868
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TJP3,Tight junction protein ZO-3,15723,135,1.47 [1.07-2.03],0.0190297404106598
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TLR4,Toll-like receptor 4,15792,137,1.76 [1.04-2.99],0.0367673175379556
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMEM132A,Transmembrane protein 132A,15876,134,1.75 [1.39-2.20],1.8855935517677217e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMPRSS11D,Transmembrane protease serine 11D,16227,141,1.86 [1.32-2.62],0.000357002816608
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMPRSS15,Enteropeptidase,18490,159,0.85 [0.72-0.99],0.0394533053576103
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMSB10,Thymosin beta-10,18585,160,1.22 [1.01-1.48],0.0435394481061642
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNC,Tenascin,18671,161,1.93 [1.47-2.54],2.5182988708354646e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNF,Tumor necrosis factor,18187,158,1.50 [1.11-2.01],0.0076527048005396
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,16196,139,1.41 [1.03-1.93],0.0304722529961797
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,18398,157,2.75 [2.03-3.73],7.852321554141656e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,18398,157,1.64 [1.38-1.95],1.639350062933469e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,18753,162,1.95 [1.45-2.61],7.749453392098926e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,18581,162,2.98 [1.97-4.49],2.207696228125184e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,18648,157,2.47 [1.79-3.40],3.0409556343015405e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,18607,162,1.59 [1.20-2.12],0.0014854235658357
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,18607,162,2.99 [2.07-4.30],4.342903540136509e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,15945,138,1.72 [1.20-2.48],0.0033381745104581
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,18723,163,2.03 [1.45-2.84],4.014414919953944e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,18585,160,2.94 [2.08-4.16],9.57279034062578e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,18585,160,1.82 [1.46-2.26],6.875810793442339e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,18723,162,2.49 [1.57-3.97],0.0001190079582403
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,18722,162,2.04 [1.50-2.77],4.9878993747539e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,18398,157,1.74 [1.42-2.13],1.1812329714197385e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,18398,157,1.64 [1.29-2.09],6.0356196424121735e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF10,Tumor necrosis factor ligand superfamily member 10,18753,162,0.47 [0.28-0.80],0.0055787139175377
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF11,Tumor necrosis factor ligand superfamily member 11,18533,160,0.79 [0.63-1.00],0.049662184654736
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF12,Tumor necrosis factor ligand superfamily member 12,18753,162,0.42 [0.26-0.68],0.0004375180273317
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF13,Tumor necrosis factor ligand superfamily member 13,18660,162,3.84 [2.39-6.17],2.506573451955668e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,18774,163,1.97 [1.34-2.91],0.0005927339960871
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF14,Tumor necrosis factor ligand superfamily member 14,18398,157,1.36 [1.07-1.73],0.012405830207059
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF8,Tumor necrosis factor ligand superfamily member 8,16282,139,1.91 [1.29-2.83],0.0013094661250439
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNR,Tenascin-R,18398,157,0.56 [0.40-0.77],0.0004155546110781
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,16274,138,1.25 [1.02-1.53],0.0315044848360385
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TOP1,DNA topoisomerase 1,16196,139,1.19 [1.03-1.37],0.0205232202738424
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPP1,Tripeptidyl-peptidase 1,18458,161,1.98 [1.56-2.52],2.4929791007519004e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,15972,137,1.27 [1.09-1.48],0.0026364382860844
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TREH,Trehalase,16282,139,0.78 [0.62-0.97],0.0270138087970953
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TREM2,Triggering receptor expressed on myeloid cells 2,18581,162,1.40 [1.08-1.81],0.0100008708498012
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIAP1,TP53-regulated inhibitor of apoptosis 1,18723,163,1.38 [1.10-1.74],0.0060516368921618
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSC22D1,TSC22 domain family protein 1,16246,139,1.27 [1.01-1.60],0.0437230790852413
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPAN8,Tetraspanin-8,16196,139,1.32 [1.13-1.55],0.0004075868481015
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TST,Thiosulfate sulfurtransferase,18110,155,1.28 [1.05-1.55],0.0145968335276029
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TTR,Transthyretin,16127,136,0.14 [0.08-0.25],1.3291893182387702e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNDC15,Thioredoxin domain-containing protein 15,18648,157,3.76 [2.32-6.09],7.478924318009853e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNDC5,Thioredoxin domain-containing protein 5,18723,162,1.54 [1.25-1.88],3.102704187340567e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TYMP,Thymidine phosphorylase,18455,158,1.32 [1.06-1.65],0.0138244131966773
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,16274,138,1.37 [1.04-1.80],0.0255697446842502
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBQLN3,Ubiquilin-3,15718,133,1.38 [1.09-1.75],0.0065083385967157
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ULBP2,UL16-binding protein 2,18398,157,2.12 [1.55-2.90],2.8427549091721886e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UMOD,Uromodulin,18748,163,0.53 [0.42-0.66],7.67385851471465e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UNG,Uracil-DNA glycosylase,16206,140,1.77 [1.14-2.76],0.0113832878270338
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",USO1,General vesicular transport factor p115,18490,159,1.21 [1.03-1.42],0.0223893797038876
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VAMP5,Vesicle-associated membrane protein 5,18206,158,1.51 [1.25-1.82],1.4819454755035732e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VCAM1,Vascular cell adhesion protein 1,18634,161,2.54 [1.64-3.95],3.3419179462746665e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VCAN,Versican core protein,18723,162,2.02 [1.29-3.15],0.0020834165010203
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFA,Vascular endothelial growth factor A,18696,162,1.55 [1.24-1.93],0.0001017331268187
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFB,Vascular endothelial growth factor B,15792,137,5.19 [3.08-8.74],5.897970529621354e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VIT,Vitrin,16274,138,2.21 [1.49-3.29],7.707710168026114e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VNN2,Vascular non-inflammatory molecule 2,18490,159,1.87 [1.33-2.63],0.0003199335007179
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,15718,133,1.68 [1.08-2.61],0.0211322996921147
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG2,V-set and immunoglobulin domain-containing protein 2,16206,140,1.72 [1.40-2.10],1.3237863573451854e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG4,V-set and immunoglobulin domain-containing protein 4,18562,159,2.14 [1.62-2.84],1.1392793522623093e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,18554,161,1.37 [1.10-1.69],0.0042497487399282
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSNL1,Visinin-like protein 1,16250,141,1.60 [1.11-2.31],0.0109364055277767
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VTCN1,V-set domain-containing T-cell activation inhibitor 1,18156,158,1.75 [1.17-2.60],0.0059080422815388
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWA1,von Willebrand factor A domain-containing protein 1,18693,163,2.40 [1.75-3.29],5.1680764338419655e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWA5A,von Willebrand factor A domain-containing protein 5A,15698,138,1.26 [1.08-1.48],0.0041831726947979
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWF,von Willebrand factor,18801,163,1.32 [1.09-1.60],0.003978034988772
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WARS,"Tryptophan--tRNA ligase, cytoplasmic",18585,160,1.70 [1.17-2.47],0.005244994562298
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WASF1,Wiskott-Aldrich syndrome protein family member 1,18206,158,1.17 [1.00-1.36],0.0493148651449648
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC12,WAP four-disulfide core domain protein 12,18694,162,1.62 [1.35-1.95],3.494828796506668e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC2,WAP four-disulfide core domain protein 2,17672,144,2.55 [2.00-3.26],4.160603543200688e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",18330,156,0.51 [0.37-0.70],3.177532182412566e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WIF1,Wnt inhibitory factor 1,18723,163,1.48 [1.01-2.17],0.0465203242256312
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WNT9A,Protein Wnt-9a,18225,158,2.15 [1.45-3.18],0.0001328230979222
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XCL1,Lymphotactin,18723,163,1.38 [1.11-1.71],0.0040731357347509
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XG,Glycoprotein Xg,18723,163,0.70 [0.52-0.96],0.0242559486685704
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XPNPEP2,Xaa-Pro aminopeptidase 2,18648,157,0.86 [0.75-0.99],0.0368700827355281
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XRCC4,DNA repair protein XRCC4,18150,155,1.50 [1.04-2.16],0.0286125902492311
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YAP1,Transcriptional coactivator YAP1,16250,141,2.04 [1.29-3.20],0.0021112441618639
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZBTB17,Zinc finger and BTB domain-containing protein 17,18206,158,1.73 [1.38-2.17],1.953035897859318e-06
